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Abstract  
Higher-order chromatin organization in cell nucleus is mysterious. Microscopy and high-
throughput sequencing technologies have been applied to reveal the connections between 
genome structure and gene transcription, which is the main topic of my thesis. Higher-order 
chromatin organization differs across cell types and species, giving an insight into disease 
genesis and tumorigenesis. Despite an enormous progress has been made recently in epigenomic 
study, lots of things remain unknown.  
My dissertation reviews the current understanding of epigenomics, characterizes 
chromatin interaction in mammalian cells using different technologies, investigates chromatin 
reorganization in breast cancer cells, analyzes integrated genomic and epigenomic data in breast 
cancer metastasis and discusses results and future directions.  
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Chapter 1 
1.1 Overview  
 Chromatin interaction is recently studied to reveal the molecular mechanisms of 
transcription regulation and disease development in mammalian cells by using high-throughput 
sequencing and microscopic imaging technologies. The investigation in chromatin interaction 
might provide novel insights into cancer therapeutics and precision medicine. 
In this chapter, I will review the current understanding of chromatin interaction and 
genome organization, the molecular mechanism of transcription regulation by DNA elements in 
different cell types including normal and cancer cells and the cutting-edge technologies in 
studying chromatin biology. Then I will outline the hypothesis and specific aims of my thesis 
projects. 
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1.2 Literature Review 
Cell nucleus contains the whole genome, stores information and decides cell fate. The 
mammalian genome comprises of meters of DNA. How the DNA is organized in the tens of 
microns cell nucleus is not fully known. The chromatin structure is dynamic over time to deliver 
accurate command for cell function. Therefore, the disorder of chromatin reorganization could 
lead to gene dysregulation and cellular abnormalities, which is often an implication of diseases.  
I will review studies in chromatin organization form different perspectives and its 
implications in cancer development especially breast cancer.  
The genome structure in three-dimension 
How chromatin is organized in eukaryotic cell nucleus is a historically mysterious 
question. It is known DNA is packed in different levels to allow meters long linear DNA 
condensed in micrometers nucleus. In 1970s, the repeating “beads on string” structure was 
observed by electron microscopy and nucleosomes were stated as the first level structural and 
functional unit for chromatin compaction1–5 (Figure 1.1). It was firstly proposed that the 
nucleosome contained around 200 bp of DNA2,6, but later it was found more accurately by X-ray 
crystal structure analysis about 146 bp of DNA were wrapped around the histone octamer to 
form nucleosomes7 (Figure 1.2), which were connected by dozens of bp of linker DNA, 
appearing as a “beads on string” structure8. The 10 nm DNA fiber is then folded into higher-
order chromatin structures that allows further compaction fitting into the nucleus. The higher-
order genome structure is elusive for tens of years. Although the 30 nm chromatin fiber structure 
was observed and proposed to be the next level structure of 10 nm fiber5,9–11, it remains 
debatable since it was only observed in vitro8,12,13. Even less is known about the higher-order 
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structure other than the putative 30 nm fiber. Therefore, more advanced technologies for in vivo 
analysis are highly desired to decipher the higher-order genome structure.  
       
  
With the development and application of DNA in situ hybridization (ISH) and 
fluorescence in situ hybridization (FISH) combined with microscopy, the whole chromosomes 
were managed to be painted and chromosome territories (CTs) (Figure 1.3) were clearly 
observed14–16 proving the DNA fibers from different chromosomes are not intermingling like 
spaghetti but compartmentalized into discrete domains in interphase nucleus. After then, this 
chromosome painting technology was applied to study chromatin organization at chromosomal 
level in different cell types. The major goal is to examine the non-randomness of CT 
arrangement and identify its connections to gene transcription and cellular function. For example, 
the studies of gene-rich (Chromosome (Chr) 19, Chr17, Chr11) and gene-poor (Chr18, Chr13, 
ChrY) chromosomes indicated gene-rich CTs were in more irregular shape (ellipsoid-like) than 
Figure 1.1 The organization of DNA within 
the chromatin structure 
The lowest level of organization is the 
nucleosome, in which two superhelical turns of 
DNA are wound around the outside of a histone 
octamer. Nucleosomes are connected to one 
another by short stretches of linker DNA.   
The figure and legend are cited from (Luger et 
al., 1997)8 
Figure 1.2 Nucleosome core particle 
Ribbon traces for the 146-bp DNA 
phosphodiester backbones (brown and 
turquoise) and eight histone protein main 
chains (blue: H3; green: H4; yellow: H2A; red: 
H2B). The views are down the DNA superhelix 
axis for the left particle and perpendicular to it 
for the right particle. For both particles, the 
pseudo-twofold axis is aligned vertically with 
the DNA center at the top. 
The figure and legend are cited from 
(Felsenfeld and Groudine, 2003)7 
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gene-poor CTs17. Another example is the CTs of Chr18 and Chr19 were delineated and 
compared in lymphoblastoid cells across primate species. It was consistently found in all the 
primate species examined Chr18 were positioned closer to nuclear periphery, while Chr19 was 
more toward the centroid of the nucleus18, implying a radial positioning of genes in cell nucleus 
for transcription regulation, which is consistent with the finding that nuclear lamina (Figure 1.3) 
or lamina-associated domains (LADs) at nuclear periphery are more heterochromatic and 
associated with transcriptional repression19. Furthermore, the relative position of certain gene 
and the CT can be transcription relevant20. During the differentiation process of mouse 
embryonic stem cells (ESCs), it was observed Hoxb genes got activated by extruding out of the 
CT, while stayed in the CT before activation21. Broadly, it has been suggested transcriptionally 
active genes are more often found on the periphery of CT20,22. There then came a speculation of 
the inter-chromosomal domain (ICD) that the CT boundaries and the space between adjacent 
CTs are decondensed and preferentially transcriptionally active with RNA transcripts released 
directly23; and it was reported ICD can facilitate information exchange and cooperation of gene 
regulation between chromosomes24. However, it does not mean gene cannot transcribe within 
CTs25.  
Recently, high-throughput next-generation sequencing technology provided an 
advantageous platform for genome structure characterization. The most hotly used are chromatin 
immunoprecipitation sequencing (ChIP-seq) of histone marks, DNase hypersensitive sites (DHS) 
and transposase-accessible chromatin using sequencing (ATAC-seq)26 to examine chromatin 
state and accessibility; high-throughput chromosome conformation capture (Hi-C)27 and 
chromatin interaction analysis using pair-end tag sequencing (ChIA-PET)28 to genome-widely 
map long-range chromatin interaction (usually from several kilobases to hundreds of kilobases) 
Dissertation          Jacqueline Jufen Zhu 
 6 
that can be reconstructed and remodeled to simulate the whole picture of the genome. Chromatin 
state or accessibility is an important indicator of the activity of gene or DNA element. For 
instances, Histone 3 lysine 27 acetylation (H3K27ac) distinguishes active enhancers from poised 
enhancers29, while Histone 3 lysine 4 trimethylation (H3K4me3) is enriched in active 
promoters30. However, it does not reflect the 3D structure of the genome as it cannot detect the 
connectivity of individual chromatin sites. Chromatin interactions suggests a looping structure 
which means two chromatin loci can physically come together even they are far away in linear 
genomic distance (Figure 1.3). Chromatin interaction is usually mediated by protein factors, 
either transcriptionally or structurally related. Transcription-associated chromatin interaction 
may form transcription factories to efficiently facilitate gene transcription31,32 (Figure 1.3). 
Overall, the interactions can be promoter-promoter, distal DNA element-distal DNA element or 
promoter-distal DNA element31,33. Of them, enhancer-promoter is the most well-studied type of 
interaction. Recently, the concept of super-enhancer was established as a region composing 
multiple enhancers involved in cellular identity bound by a series of master transcription 
factors34. Theoretically, by reconstructing and remodeling the genome-wide interactions, we will 
be able to depict any compartment and even the whole picture of the genome35,36. According to 
the chromatin interaction frequency of cell population, a structure with mega bases of DNA was 
defined as topologically associating domain (TAD) (Figure 1.3) that is conserved across cell 
types in a given organism37,38, but may differ between cell lineages36,39. Within TAD, chromatin 
contacts occured remarkably more frequent than those outside40. Extensive studies have found 
TAD plays important roles in transcription regulation and DNA replication41,42.  
Similar to TAD, insulated neighborhood was proposed to be the mechanistic basis of 
TAD. Insulated neighborhood is defined as a CCCTC-binding factor (CTCF)-CTCF confined 
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chromatin loop, with at least one gene inside, CTCF binding at both anchor sites, co-bound by 
cohesin. It provides an insulated region for specific enhancer-promoter interaction and 
transcription. Based on the definition, at least 50% of the TADs are insulated neighborhoods in 
mammalian cells43.  
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Figure 1.3 Different Levels of 
Genome Organization  
From top to bottom: Level 1: 
Chromosomes occupy distinct 
subregions of the nucleus known as 
chromosome territories (CTs). 
Individual chromosomes are 
indicated by different colors. Level 
2: Transcriptionally inactive regions 
are enriched at the nuclear 
periphery, where they contact the 
nuclear lamina (red). Actively 
transcribed genes often colocalize at 
RNA polymerase II transcription 
factories (yellow). These and other 
instances of colocalization between 
regions with similar transcriptional 
activity may provide the physical 
basis for the observations of A and 
B compartments in C data. Level 3: 
Topological domains, or 
topologically associating domains 
(TADs), are regions of frequent 
local interactions separated by 
boundaries across which interactions 
are less frequent. CTCF binding 
sites and other sequence features are 
enriched at TAD boundaries. Note 
that CTCF also binds within TADs. 
Cohesin is often present at TAD 
boundaries, although it is not shown 
here. Level 4: Transcriptional 
regulation depends on long-range 
interactions between cis-regulatory 
elements such as enhancers (light 
red) and promoters (light yellow). 
These cis-regulatory interactions are 
facilitated by proteins including 
transcription factors (TFs; blue), 
cofactors such as Mediator (Med; 
red) and Cohesin (purple ring), and 
RNA polymerase II (Pol II; yellow). 
The figure and legend are cited from 
(Gorkin et al., 2014)128 
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Methods to study chromatin organization 
The most often used methods to investigate chromatin organization are DNA FISH 
combined with microscopy, high-throughput sequencing combined with molecular library 
construction and genome editing including clustered regularly interspaced short palindromic 
repeats (CRISPR)44 or transcription activator-like effector nucleases (TALEN)45 systems.  
FISH assays have been applied to stain interest chromatin regions, sizing from dozens of 
kilobases to the whole chromosome, followed by microscopic imaging. The two most critical 
factors affecting staining capabilities and imaging qualities are DNA probes and microscopic 
resolution. Probes for CT and whole chromosome are already well-established. However, to 
study ultrastructure such as chromatin interaction, which usually spans hundreds of kilobases of 
DNA with two interacting loci of only several kilobase length at the anchors, regulator bacterial 
artificial chromosome (BAC) originated probes can hardly fulfill the requirement as each BAC 
probe stains about 200 kb DNA lacking accuracy and specificity. To overcome this shortage of 
regular probes, oligopaints have been developed with advantages in staining accuracy, specificity 
and flexibility46. Basically, oligopaints can be designed to stain any desired chromatin regions by 
pooling microarray probes. It has been successfully applied to distinguish homologous 
chromosomes47 and evaluate chromatin state48. Regarding microscopy technologies, the trend is 
to bypass the diffraction barrier, break the resolution limit of 200 nm inherent in conventional 
microscopy, and achieve super resolution. Though electron microcopy has higher resolution than 
conventional microscopy, it is not easy to apply in studying chromatin structure due to the 
limitation of labeling. I will only review super-resolution light microcopy in this chapter. Of all 
the super-resolution microscopic technologies, there are three main methods that have been 
widely used:  structural illumination microscopy (SIM)49, stimulated emission depletion 
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(STED)50 and photoactivated localization microscopy/stochastic optical reconstruction 
microscopy (PALM/STORM)51,52. Beyond the basic two-dimension (2D) imaging, 3D SIM53, 
3D STED54, 3D STORM55–57 and interferometric PALM (iPALM)58 have been developed to be 
more powerful for 3D genome study47,59–62. Recently, these super-resolution imaging 
technologies were largely utilized in investigating chromatin structure. Epigenetic states63,64 and 
TAD65 inferred by sequencing data were imaged and analyzed by STORM, validating the 
predictions made from sequencing data. Whereas, the biggest limitation of imaging-based 
methods is low-throughput that only a few cells can be imaged at a time.  
Next-generation sequencing provided an efficient platform for genome structure study 
with cell populations (Figure 1.4). As mentioned previously, ChIP-seq with histone mark 
antibodies are very commonly used to investigate the distribution of certain chromatin state, 
active, inactive or poised. Similarly, DNase and ATAC-seq are also used to identify chromatin 
state, but can only classify it into two states, either open (transcriptionally active) or closed 
(transcriptionally inactive). More importantly, proximity ligation-based technologies came out to 
capture chromatin contacts and map its 3D organization66. Chronologically, chromosome 
conformation capture (3C)67 was firstly developed to capture one-to-one interactions. After then, 
circular chromosome conformation capture (4C)68 and chromosome conformation capture carbon 
copy (5C)69 came out at about the same time to identify one-to-many and many-to-many 
chromatin contacts, respectively. In 2009, Hi-C27 and ChIA-PET28 were firstly reported to 
capture chromatin interactions genome-widely in an all-to-all manner. The differences between 
Hi-C and ChIA-PET is that Hi-C captures all the chromatin interactions while ChIA-PET 
selectively captures a subset of interactions mediated by interest protein factors. Both Hi-C and 
ChIA-PET have nonnegligible shortcomings: Hi-C needs billions of sequencing reads and ChIA-
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PET requires millions of cells. To overcome these difficulties, novel technologies have been 
developed recently such as HiChIP70, Capture Hi-C71 and others.  
 
   Figure 1.4 Overview of 3C-derived methods 
An overview of the 3C-derived methods that are discussed is given. The horizontal panel shows the 
cross-linking, digestion, and ligation steps common to all of the ‘‘C’’ methods. The vertical panels 
indicate the steps that are specific to separate methods.  
The figure and legend are cited from (Wit and Laat, 2012)66 
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Besides DNA FISH imaging and genome sequencing, genome editing tools such as 
TALEN and CRISPR44 have also be used to validate chromatin interaction inferred by 
sequencing data. Specifically, multigene co-transcription, enhancer regulation on gene promoter 
and CTCF mediated repressive chromatin loop43,72,73 were validated functionally using 
TALEN74,75 and CRISPR/Cas976,77 for genetic editing. More interestingly, other than genetic 
editing, CRISPR/dCas9 can be applied in epigenetic modification on target chromatin site, in 
order to modulate gene transcription78. In the other way around, functional CRISPR screening 
enables to map chromatin interaction and identify enhancers79–83, providing a novel insight into 
genome structure investigation.  
Key regulators of genome structure 
Genome architecture is established with known and unknown factors involved. The most 
well-studied protein factors driving chromatin organization are CTCF, cohesion and RNA 
polymerase II (RNAPII). Recently, Yin Yang 1 (YY1) was reported to regulate enhancer-
promoter interaction. In addition, some long non-coding RNA (lncRNA) such as X-inactive 
specific transcript (Xist) and functional intergenic repeating RNA element (Firre) also play 
important roles in genome structure conformation. 
 CTCF is a highly conserved protein from fly to human. 3D genome studies found CFCF 
is a key genome organizer that mediates chromatin contacts, bridging the gap between the 
working mechanism and its contradictorily diverse functions. As a gene activator, CTCF can 
tether promoters with their enhancers or other promoters, forming a transcription complex to 
promote gene expression33,84,85. As an insulator, CTCF was observed to enrich at the boundaries 
of TAD36,37, demarcating the TADs from interacting with each other, thus, inhibited information 
exchange between enhancers and promoters to repress gene transcription. It was proved by 
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interrupting the TAD boundary, genes expressed ectopically43,86,87. Furthermore, ChIA-PET 
analysis showed CTCF binding motif orientation is related to transcription35, connecting delicate 
CTCF positioning with gene activity.  
 Cohesin is another important architectural regulator functioning similarly with CTCF. It 
is a protein complex composed of subunits Smc1A, Smc3, Rad21 and Stag1/2. Cohesin 
colocalize heavily with CTCF locating at the boundaries of TAD37 and mediating chromatin 
interaction associated with gene activation or repression. However, cohesin can bind chromatin 
site independently of CTCF. For example, cohesin was found to interact with Mediator to 
contribute to chromatin looping and co-occupy active gene promoters and enhancers in ESCs88. 
Despite the similar functions as genome organizers, cohesin and CTCF affect chromatin 
organization differentially. A general loss of local chromatin interactions by disrupting cohesin 
was observed, but the TADs remain intact. Whereas, the depletion of CTCF not only reduced 
interactions within TADs but also increased interactions across TADs89. Furthermore, distinct 
groups of genes become dysregulated upon depletion of cohesin and CTCF89.  
 RNAPII is an essential subunit of transcription factors for gene transcription in 
eukaryotic cells. ChIA-PET analysis showed RNAPII mediates transcriptionally related 
chromatin interaction. In most of the cases, RNAPII mediated chromatin interactions are shorter 
than and residing in CTCF/cohesin mediated ones35.  It is often used to identify potential 
enhancers and examine enhancer reorganization by studying RNAPII mediated chromatin loops.  
 YY1 is a transcription factor in mammalian cells90–92. Only recently, YY1 was found to 
be involved in chromatin interactions between enhancers and promoters across cell types93.  
 Xist is a well-known lncRNA functioning to inactivate one of the X chromosomes in 
female cells. Xist express and spread over in cis to silence the whole X chromosome. It is still 
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not clear how Xist inactivates X chromosome. Comprehensive Xist interactome study revealed 
Xist repelled architectural factors such as cohesin from the inactive X chromosome (Xi), 
directing a specific chromosome conformation of Xi94.  
 Firre is a structural component of nuclear matrix expressed in X chromosome. However, 
its role in shaping genome structure is poorly understood. Firre was found to express locally at X 
chromosome but interact in trans with genes at autosomes95, suggesting a modulation 
mechanism across chromosomes. Additionally, by ChIA-PET analysis, super long chromatin 
loops projected out from Firre genomic locus to both sides only at active X chromosome (Xa) in 
GM12878 cells35, consistent with  the knowledge that Xi and Xa are in different chromosome 
conformation, implying the contribution of Firre. 
Chromatin reorganization in diseases 
Higher-order chromatin organization is one of the critical factors driving gene 
transcription, which is different across cell types and species. It is natural to assume chromatin is 
reorganized in disease cells. Studying disease-associated genome structures reveals fundamental 
mechanisms underlying disease genesis, providing insights into therapeutics. I will review the 
reorganization in diseases from different levels of CT, TAD, insulated neighborhood and 
enhancer-promoter interaction.  
In immune-deficiency centromeric instability facial anomalies (ICF) syndrome, PAR2 
genes were reorganized to localize toward the outside of Xi and Chromosome Y (ChrY) CTs, 
accompanying with loss of DNA methylation on Xi96. This is a direct reflection of connections 
between CT reorganization and disease. Indirectly, translocations prefers to occur between 
neighboring chromosomes instead of chromosomes that are far away from each other97,98. Hence, 
translocation-associated disease is attributed to the organization of CTs to some degree.  
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TAD is a highly self-interacting chromatin domain discussed previously. It maintains 
frequent interactions inside these discrete compartments but prevents interactions across them. 
Disruption of TADs can cause ectopic gene expression and diseases. For instance, the altered 
chromatin structure at WNT6/IHH/EPHA4/PAX3 locus spanned by TADs is the cause of a 
distinct human limb malformation. By disrupting the TAD boundary in normal mice, enhancers 
and promoters ectopically rewired across TADs, resulting pathogenic phenotypes, suggesting a 
molecular mechanism for limb malformation86. Another example is about T-cell acute 
lymphoblastic leukemia (T-ALL). The perturbation of insulated neighborhood boundaries in 
non-malignant cell activated T-ALL proto-oncogenes73. Somatic mutations, DNA 
hypermethylation and structural variations at the anchor sites of insulated neighborhoods were 
found to contribute to oncogenesis73,99,100.  
Enhancer-promoter interaction is the most straightforward structure regulating gene 
transcription. Enhancer malfunction could be the cause of diseases. Genetic or epigenetic 
variations such as point mutations101 and aberrant methylation102,103 on enhancers were found to 
contribute to cancer development and tumor progression. In colorectal cancer71 and breast 
cancer104, enhancer arrangements were observed changed compared with normal cells. A region 
containing a cluster of enhancers occupied by Mediator and other master transcription factors 
was found to suggest cellular identify and defined as super-enhancer34. Super-enhancers were 
widely studied in a variety of diseases and cancers such as lymphoma105,106, myeloma107 and T-
ALL108. The acquisition of super-enhancers at oncogenes during the process of tumor 
development could be the driver pathogenesis109. 
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New insights into genome structure 
Despite higher-order genome structure has been studied for about half a century, lots of 
unknown remains. 
It is hard to ignore that the limitations of current technologies stopping us from diving 
deeper into the genome structure. Though DNA probing and imaging allows us to visualize the 
chromatin organization directly, the resolution is relatively low. We can hardly handle to resolve 
the DNA arrangement at kilobase level, not to say base level. The advantage of sequencing 
methods is that it gives a better resolution than imaging. However, it requires a relatively large 
number of cells. What we have acquired from sequencing data is an averaged information but not 
accurate for each cell individual, which ignored heterogeneity across single cells.  
 Many studies focused on those key regulators on genome organization, but may 
overestimate their function. As Denes Hnisz reviewed110, TADs and gene transcription inside 
were not affected upon CTCF depletion by some studies, suggesting gene activation or 
repression play important roles in genome arrangement in CTCF-independent manner. This 
debated observation suggested the key regulators may not be truly “key” at all times but only 
under particular circumstances. 
An interesting argument is whether the genome structure is the cause or consequence of 
gene transcription, or both. Based on current knowledge, it seems the answer is both. It is like a 
circuit, the arrangement of the genome somehow determines the gene transcription, vice versa, 
the transcribed gene functions to further shape the genome structure, till an internal balance 
achieved. The balance can be broken by operational mistakes such as genetic mutations or 
external stimuli. The cell will search to re-achieve another round of balance, till die.  
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1.3 Hypothesis and Specific Aims  
Project 1 Visualization of chromatin loop in human cells 
How meters long chromatin is packed in micrometer-scale cell nucleus is mysterious. 
The 3D structure of the genome is of fundamental importance for gene regulation and cellular 
function. Methods to study 3D genome include molecular biology tools combined with next 
generation sequencing and DNA staining combined with microscopic imaging. Regarding 
sequencing, ChIA-PET and Hi-C technologies are most often used to capture higher-order 
genome organization in kilo base resolution. Chromatin imaging can directly visualize genome 
positioning using DNA FISH followed by microscopy. 
Recent studies in genomics based on sequencing technologies inferred the very basic 
functional chromatin folding structures known as chromatin loop. Long-range chromatin 
interactions take place in nuclei are often mediated by protein factors at the loop anchor loci. 
Due to theoretical and technical limitation of conventional microscope, the chromatin loop 
cannot be resolved. To prove the existence of chromatin loop and elucidate its finer structure, 
super-resolution microscopy is a powerful technology to be applied. iPALM is one of the most 
well-established super-resolution microscopies that can resolve chromatin 3D structure at single 
molecule level.  
Hypothesis/Rational 
Hi-C and ChIA-PET contact map data showed chromatin loops at various genomic loci 
and length scales. After examining the whole genome, the target chromatin loop region was 
selected at chromosome 14, which contains a high frequency loop that is about 13kb long and 
mediated by both CTCF and RNAPII in GM12878 cells. Super-resolution microscopy such as 
STORM has been recently used to image functional chromatin domains TAD and epigenetic 
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states63,65. iPALM can achieve even higher resolution than STORM axially, which makes it 
promising to resolve finer genome structures such as chromatin loop. By visualizing the target 
chromatin loop, I expected to see a major looping structure inferred ChIA-PET and Hi-C data. 
Possibly, there could be more complex structures beside the major loop.  
Specific Aim  
Aim Super-resolution imaging of a distinct chromatin loop in human lymphoblastoid cells. 
I applied super-resolution microscopy iPALM to image a distinct chromatin loop inferred by 
ChIA-PET in human lymphoblastoid GM12878 cells. I then processed the images for 3D 
modeling and compared it with genomic data for evaluation. 
Project 2 Identification of metastasis-associated chromatin interaction and gene 
network 
Beyond studying chromatin interaction in normal cells, we also aim to investigate 
chromatin interaction and genome structures in breast cancer cells and identify metastasis-
associated structures. Implied by connections between DNA elements, we can identify novel 
genes and investigate the underlying molecular mechanisms in diseases and cancer. 
Breast cancer lethality is primarily due to tumor metastasis to other organs such as the 
lungs, liver and brain. Despite this, relatively little is understood about the etiology and 
molecular mechanism of metastasis. Although previous works have identified genes whose 
dysregulation is likely to be involved in metastasis111–119, more needs to be studied in a 
comprehensive way.  
One promising lead comes from the aspect of DNA element regulation on transcription. It 
has been shown that chromatin interactions between gene promoters and distal enhancers can 
regulate gene expression and establish cellular identity, the disruptions in which can lead to 
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disease states31,86,120. By analyzing the global transcription and chromatin interaction in three 
mouse mammary tumor-derived cell lines (4T1, 4T07 and 67NR) that vary in metastatic 
potential121,122 although derived from the same tumor, we can identify metastasis-associated 
genes and their regulatory elements. Further exploration on the functional consequences by 
disrupting specific interactions using a genome-editing approach will provide more evidences to 
prove the role of the regulatory elements. 
By integrating polymorphic differences in mouse strains with differing metastatic 
capacities with chromatin accessibility and interaction information to investigate the metastatic 
cascade, we are able to identify genes involved in disseminated cell to metastatic lesion. By 
implementing pathway analysis and validation, it will provide novel insights into the mechanism 
of metastatic colonization for potential clinical intervention. 
Specific Aim 
Aim 1 Investigation of enhancer regulation on metastasis by chromatin interaction in 
mouse cells lines. This aim is to interrogate enhancer regulation on metastasis associated genes 
by characterizing genome-wide transcription and chromatin interaction combined with genome 
editing validation. 
Aim 1a Profiling transcription, chromatin accessibility and chromatin interaction of a 
series of mouse cell lines. With 4T1, 4T07 and 67NR cells, I profiled the gene transcription by 
RNA-Seq, characterized chromatin accessibility by benzonase-accessible chromatin (BACh) 
analysis, and mapped chromatin interactions by ChIA-PET, specifically examining interactions 
mediated by RNAPII.   
Hypothesis/Rationale: I used a mouse cell model, a series of cell lines 4T1, 4T07 and 67NR 
derived from the same spontaneous mammary tumor of BALB/c mouse that show various 
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degrees of metastatic potential from high to low123. RNA-seq, BACh and ChIA-PET analysis 
gave us a very comprehensive view of all the three cell lines to study metastasis, given the 
hypothesis of chromatin reorganization leading cancer metastasis.  
Aim 1b Identification of metastasis-associated transcription and chromatin interaction. By 
comparative analysis of datasets from Aim 1a for the three cell lines, I identified differential 
expressed genes especially 4T1 up-regulated genes that are most likely metastasis associated. 
Combining the identified genes with BACh and ChIA-PET data, I further identified chromatin 
interactions between potential enhancers and gene promoters associated in metastasis in 4T1 
cells.  
Hypothesis/Rationale: With the differences of metastatic predispositions in 4T1, 4T07 and 
67NR cells though from the same tumor, comparative analysis of their transcription, chromatin 
accessibility and chromatin interaction reveal the higher-order regulatory mechanism for gene 
transcription. 
Aim 1c Validation of enhancer function in metastasis. Informed by the results from the Aim 
1b, I disrupted the target chromatin interactions by knocking out the enhancer in metastatic 4T1 
cells using CRISPR/Cas9 system to interrogate transcriptional and phenotypic changes in cell 
adhesion and migration. 
Hypothesis/Rationale: Informed by the results from Aim 1a and Aim 1b, enhancers are 
candidate targets in transcription regulation. Thus, it is meaningful to validate enhancer function 
by knocking it out to interrupt the interaction with target genes. In 4T1 cells, knocking out the 
identified enhancer from Aim 1b could suppress target gene expression and metastatic 
phenotypes. 
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Aim 2 Identification of a core metastasis susceptibility network by integrating genetic, 
epigenetic and chromatin interaction analysis. 
Aim 2a Identification of polymorphic BACh sites that potentially promote metastasis. I 
identified 4T1-specific BACh sites based on BACh analysis mentioned in Aim 1. In parallel, I 
compared the single nucleotide polymorphisms (SNPs) in five pairs high- and low-metastatic 
mouse strains (BALB/cj (high) and SEA/GnJ (low); AKR/J (high) and RF/J (low); C57BL/10J 
(high) and C57BR/J (low); C57BL/10J (high) and C58/J (low); CAST/Ei (high) and MOLF/Ei 
(low)) to filter for the SNPs specifically located in low metastasis strains that potentially 
suppress metastasis. To enrich for chromatin sites affecting metastasis progression, I identified 
4T1-specific BACh sites that have filtered low metastasis associated SNPs residing in.  
Hypothesis/Rationale: Based on human studies, it indicates that the majority of disease-
associated polymorphisms are non-coding124 and therefore likely mediate their effects through 
subtle changes in gene transcription125,126. Previously study showed the five low- metastasis 
mouse strains were derived from a highly metastatic strain FVB/NJ inbred to other mouse strains. 
We assumed the acquired low metastatic potential were due to the differed genetic background 
of the parental mouse strains. Different mouse strain pairs that are close phylogenetically but 
with high- and low- metastasis were used for SNP analysis. SNPs unique in low metastatic 
strains are implied to associate with metastasis, therefore, the alteration of which in metastatic 
cells is one probable reason to cause metastasis susceptibility. The polymorphic BACh sites 
mapped out by BACh sites with those low-metastasis-associated SNPs inside in metastatic 
mouse cell were identified to be metastasis associated via promoter or non-promoter regulation 
on target genes. 
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Aim 2b Identification of candidate metastasis susceptibility genes and pathways. I mapped 
out the connectivity between potential regulatory elements and gene promoters using RNAPII 
ChIA-PET. Combined with identified polymorphic BACh sites that associate with metastasis 
susceptibility, I identified candidate metastasis susceptibility genes in each pair of mouse strains. 
By intersecting the genes identified from the five pairs of mouse strains, I got a core set of 
metastasis susceptibility gene candidates. To better understand the potential function of these 
candidate genes, I performed pathway analysis to categorize the functions and build up the 
network for metastasis development.  
Hypothesis/Rationale: Genes associated with identified polymorphic BACh sites in Aim 2a 
would be enriched for factors necessary for the conversion of dormant solitary tumor cells to a 
proliferative metastatic lesion. Based on this hypothesis, the application of ChIA-PET can 
improve the specificity to identify genes and pathways associated with metastasis. Previously, 
putative candidate genes were identified by proximity to DHS and subsequent analysis indicated 
that these candidates were enriched for factors and mechanisms associated with progression in 
both mouse models and human breast cancer patients. Despite the success of these studies, two 
major limitations were present that decreased the specificity of this analysis. First, whole genome 
DHS data does not permit refinement or filtering of candidate genes for specific points along the 
metastatic cascade, specifically at the most clinically relevant point of the dormant-to-
proliferative transition. Second, identification of candidate genes by proximity to DHS sites 
introduces significant false positive and false negative data, since it is known that chromatin 
structure can bring distant enhancers into contact with promoters by looping. By mapping the 
chromatin interactions such as enhancer-promoter interactions, it is more specific and trustable to 
identify the genes connected with polymorphic BACh sites. 
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Aim 2c Validation of identified genes and pathways. To investigate the role of genes and 
pathways within the identified candidates in Aim 2b, I selected glucocorticoid receptor signaling 
for validation. I implanted 6DT1 cells into mice and treated them with dexamethasone to activate 
glucocorticoid signaling. By comparing the local and metastatic tumor burden between 
dexamethasone-treated and control mouse group, the influences of glucocorticoid signaling 
pathway was evaluated. 
Hypothesis/Rationale: As a set of genes and pathways were identified to be associated with 
metastasis using genetic and epigenetic tools in Aim 2b, within which, some are novel that have 
never been reported. It is meaningful to further validate their important roles by animal 
experiment.  
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1.4 Background and Significance 
Recent 3D genome studies demonstrated genomic distance is not always consistent with 
physical distance in vivo, linear arrangement of the genome cannot fully represent the 
mechanism responsible for transcription regulation. Techniques that combine biochemistry with 
high-throughput sequencing such as Hi-C and ChIA-PET have been used to map chromatin 
loops that physically interact at long distances, and these interaction maps have been used to 
infer the 3D structures of the genome. Comparative analysis of different cells showed that the 
higher-order genome organization such as chromatin interactions could lead to cell-specific 
transcription by shaping nuclear topology, and suggested enhancer-promoter interactions 
significantly enriched for cell-specific functions.  
Due to limitations in imaging resolution inherent to conventional microscopy, the spatial 
organization of higher-order chromatin structure has historically been difficult or impossible to 
directly observe. With the application of super-resolution microscopy, people started to see 
functional genome structures inferred by sequencing data. For example, STORM combined with 
DNA FISH has been used to image chromatin folding of TAD and different epigenetic states 
inferred by Hi-C63,65. However, more detailed structures beyond TAD such as chromatin loop are 
still elusive. As one of the most well-established super-resolution light microscopies that can 
achieve the best resolution up to 20 nm axially, iPALM will provide the best chance to resolve 
the most fundamental functional chromatin unit. 
Breast cancer is the most common malignancy and the second leading cause of cancer-
related deaths among women (https://seer.cancer.gov/statfacts/html/breast.html). Although recent 
evidence suggests that some improvement has also been seen over the years for patients with 
metastatic disease127, disseminated tumors remain the proximal cause of the majority of breast 
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cancer deaths. Improved understanding of the unique dependencies and vulnerabilities of 
disseminated tumor cells and their resulting macroscopic lesions would therefore have the 
potential to improve patient survival by exploitation of metastasis-specific targets and pathways 
to eliminate life threatening metastasis. 
Molecularly, metastasis results from ectopic gene expression that is affected by genetic 
and epigenetic events. Therefore, comprehensive study is necessary by combining genetic and 
epigenetic analysis based on genome-wide sequencing technologies. 
A central aim in this study is to dig out the regulatory elements especially enhancers and 
understand the mechanism of distinct genome organization that programs the cellular function 
and biological processes. Studies in genome organization and gene regulation have provided new 
insights into transcription regulatory mechanisms and disease development109,128,129. Via 
chromatin looping enhancers can affect the expression of target genes located far away in linear 
distance. It has been reported that disease-associated variation is especially enriched in enhancers 
of disease-relevant cell types, and cancer cells generate enhancers at oncogenes and other genes 
important in tumor pathogenesis. Hence, higher-order chromatin conformation could be a critical 
determinant in breast cancer metastasis. 
As a result of genetic screen in mouse models, SNPs that are found to be associated with 
differential metastatic capacity can be utilized as “fingerprints” on the genome to indicate which 
genes, regardless of previous knowledge or known functionality, play important roles in tumor 
progression. These “fingerprints” can subsequently be used to retrospectively construct the 
probable biology along the metastatic cascade on which genes or DNA elements act without 
direct observation. Based on a genetic screen that demonstrated a significant role of inherited 
SNPs in the progression of a transgene-induced model of mammary tumor metastasis130,131, a 
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number of genes have been implicated in the predisposition of this mammary tumor model to 
form pulmonary metastatic lesions115,132,133, several of which have also been potentially 
implicated in human metastasis susceptibility133–137. Although these studies have implicated new 
genes in tumor progression, each appears to contribute relatively small amounts of the 
phenotypic variance, suggesting that metastasis susceptibility is a complex trait that is the 
combined result of many different genes acting additively or interactively. In order to more 
comprehensively and specifically interrogate the targets genome-widely, it is promising to utilize 
sequencing tools that map the epigenomic features combined with SNPs to identify genes and 
pathways that are associated with metastasis but missed in traditional genetic studies.  
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1.5 Outline 
 This thesis consists two projects to study chromatin interaction in mammalian cells. Each 
aim of the projects is described and discussed in the following chapters.  
 Chapter 2: Super-resolution imaging of a distinct chromatin loop in human 
lymphoblastoid cells 
 Chapter 3: Investigation of enhancer regulation on metastasis by chromatin 
interaction in mouse cells lines 
 Chapter 4: Identification of a core metastasis susceptibility network by integrating 
genetic, epigenetic and chromatin interaction analysis. 
 The last chapter concludes the results and findings and discusses the limitations and 
future directions. 
 Chapter 5: Conclusions, limitations and future directions 
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Chapter 2: Super-resolution imaging of single 
chromatin loop in human lymphoblastoid cells 
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Chapter 2 
2.1 Introduction 
Chromatin organization is a fundamental mechanism for gene transcription regulation. 
DNA is condensed in different levels in cell nucleus. The lower level 10 nm DNA fiber is folded 
into higher-order chromatin structures that allows further compaction fitting into the nucleus 
which tightly associate with transcription regulation and cellular function. The higher-order 
genome structure is elusive for tens of years. Advanced technologies for in vivo analysis are 
highly desired to decipher the higher-order genome structure. Recently, technologies combining 
biochemistry and high-throughput sequencing such as Hi-C and ChIA-PET have been developed 
to genome-widely characterize long-range interaction (usually from several kilobase to hundreds 
kilobase) that is considered as the basis of higher-order chromatin organization in order to map 
the whole genome structure. Chromatin interactions suggests a DNA looping and folding 
conformation that distant chromatin loci can physically contact with each other. Based on 
mapped chromatin interactions, complex structures with mega bases of DNA such as TAD 
and CTCF-mediated chromatin contact domain (CCD) have been proposed and defined. More 
importantly, these sequencing inferred structures were proved to be involved in transcription 
regulation and disease development. Thus, they have critical biological importance. However, 
the visualization of these hypothesized higher-order chromatin structures in situ remains difficult 
mainly due to resolution limitation of conventional microscopy. Though electron microscopy had 
been used to visualize the ultrastructures and 3D organization of chromatin directly138,139, it 
lacked specificity with the restriction of labeling methods to be used in investigating 
transcription associated chromatin structures. Fortunately, super-resolution light microscopy has 
made it possible to achieve the goal. Recently, STORM has been used to image chromatin 
Dissertation          Jacqueline Jufen Zhu 
 30 
folding of TAD and different epigenetic states inferred by Hi-C63,65. With this success, there 
comes a more intriguing challenge to visualize a distinct chromatin loop. In this study, we 
applied super-resolution microscopy iPALM combined with FISH to visualize a specific 
chromatin loop that very frequently occurred in human lymphoblastoid GM12878 cells inferred 
by Hi-C and ChIA-PET chromatin contact data, which enabled us to resolve the very fine 
chromatin looping structures within 33 kilobases of DNA. 
The iPALM imaging was done in Janelia campus, Howard Hughes Medical Institute, 
helped by Jesse Arron. The chromatin modeling and analysis were mostly done by Zofia Parteka 
and Przemyslaw Szalaj in University of Warsaw.   
Dissertation          Jacqueline Jufen Zhu 
 31 
2.2 Materials and Methods 
Cell culture 
GM12878 cells were cultured in RPMI 1640 with 2mM L-glutamine and 15% fetal bovine serum 
at 37 °C. 
Nuclei isolation 
Nuclei EZ Prep Nuclei Isolation Kit from Sigma was used to isolate nuclei from GM12878 cells. 
Coverslip coating 
Coverslips were incubated in 1M KOH for 20min, washed with water, coated with 0.01% poly-
L-lysine (Sigma) for 20min, rinsed with water, dried for 30min for later use. 
DNA FISH 
Isolated nuclei were added to attach to poly-L-lysine coated coverslips, fixed with 4% PFA for 
10min at room temperature, washed with 1x phosphate-buffered saline (PBS), permeabilized 
with ice-cold methanol for 10min, washed with 1 x PBS, dehydrated with 75%, 85% and 100% 
ethanol for 2min each, dried at 60°C for 1h. FISH probes were mixed with hybridization buffer 
and added to prepared nuclei, denatured at 80°C for 5min, incubated in a humid chamber at 37°C 
for overnight. Nuclei were washed with 50% formamide/2 x SSC at room temperature for 10min, 
followed by 2xSSC for 10min, 0.2 x SSC at 55°C for 10min and then large volume of 2 x SSC 
till imaging. 
iPALM imaging 
Samples were imaged in standard STORM buffer by iPALM (Shtengel et al., 2009).  Isolated 
nuclei were adhered to 25mm round coverslips containing gold nanorod particles that act as 
calibration standards and alignment/drift fiducial markers.  These were prepared as described in 
(https://www.sciencedirect.com/science/article/pii/B978012420138500015X).  Briefly, coverslips were 
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washed for 3 hours at 80 degrees C in a 5:1:1 solution of H2O:H2O2:NH3OH, rinsed copiously, 
and coated with poly-L-lysine.  After further washing, gold nanorods (Nanopartz, Inc) were 
adhered to poly-L-lysine coated coverslips, washed again, and coated with ca. 50nm SiO2 using 
a Denton vacuum evaporator. Samples were mounted in dSTORM buffer140, containing tris 
buffered saline, pH 8, 100mM mercapto ethanolamine, 0.5 mg/mL glucose oxidase, 40 ug/mL 
catalase, and 10% (w/v) glucose (all from Sigma). An 18mm coverslip was adhered atop the 
bottom coverslip, sealed, mounted in the iPALM, and imaged as described above.  
Image pre-processing 
iPALM images were reconstructed via localization of blinking fluorophores over 25,000 frames 
across each of three Electron-multiplying charge-coupled device (EMCCD) cameras. Gold 
nanoparticles act as fiducial markers that allow for (1) spatial registration of the three cameras 
using a full affine transformation, and (2) calibration of the z-position response of the 
system.  After localization, images were filtered to only include localizations with <30nm 
uncertainty in all three dimensions.  The gold fiducial particles also allow for drift correction in 
all three dimensions, and for correcting any sample tilt to within 30nm error.  Final images were 
rendered as image stacks, reflecting the fluorophore density and uncertainty of localization, or 
exported as ASCII delimited text files for further analysis. 
Spots identification 
Connected component in graph theory is a set of nodes (subgraph) such that all of the nodes are 
connected by vertices. In image processing we are looking at voxels with different brightness 
levels. We defined a connected component as a part of the image in which all of the voxels form 
an area with brightness level above given threshold. By changing the brightness cutoff level, we 
can split an image into different sets of connected spots (Figure 2.4).  
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Algorithms for connecting identified spots 
To comprehensively model the peak joining possibility, we applied three different algorithms to 
render the models. After that we apply spline Interpolation to smooth the models. 
Nearest neighbor (NN) algorithm   Nearest neighbor algorithm is solving shortest path problem. 
Shortest path problem in graph theory is the problem of finding a path between two nodes such 
that the distance between them is minimized. Algorithm is starting from given point, searching 
the nearest point in surroundings, connecting them and again searching for the nearest neighbor 
and this way connecting a whole set of points. After analyzing the genomic data, we found out 
that examined loop is in between two subdomains. We assumed that flanking regions will be far 
apart from each other with the loop in the middle. We run two NN simulations each starting from 
one of two points that were furthest apart in space. Thus, this program will generate two possible 
image models.  
Traveling salesman problem solver (TSP) algorithm   We used implementation of greedy 
algorithm finding one of best solutions for this NP-hard problem. We treat our set of points as 
graph nodes, and distances between them as vertices. At the beginning each vertex is a separate 
path of length 1. In each step we are finding two closest disconnected paths, and we connect 
them into one. This step is repeated until there is just one path left. Greedy TSP solver gives 
highly non-optimal results therefore after connecting all paths into one we run optimization 
algorithm. Optimization tries to rearrange points in the path to improve the solution.  After 
finding the shortest path we are simply deleting the longest connection between two points. This 
way we get the shortest path between two points that are the furthest from each other. 
Neighbor joining (NJ) algorithm   Neighbor Joining is an agglomerative clustering method used 
in bioinformatics for creation of phylogenetic trees. In each step the algorithm is searching for a 
Dissertation          Jacqueline Jufen Zhu 
 34 
pair of points that are the closest to each other and connecting them in one. This step is repeated 
until there is no unconnected points left. We used this approach to connect sets of points from 
iPALM images. 
Spline Interpolation 
This is a type of interpolation which uses splines, special polynomials, to construct new set of 
data points. We used it to smooth structures after connecting spots from iPALM images. 
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2.3 Results 
Chromatin landscape of target region and visualization by DNA FISH         
Hi-C and ChIA-PET data both showed chromatin loops at various genomic loci and 
length scales. After we examined the whole genome, we selected the target genomic region in 
chromosome 14, which contains a high frequency loop that is about 13kb long and mediated by 
both CTCF and RNAPII in GM12878 cells (Figure 2.1B and Figure 2.2). It is located at the T-
cell receptor alpha (TCRA) locus where V(D)J recombination takes place during T-lymphocyte 
development and has been observed and studied in mouse T cells141–143. Specifically, a CTCF- 
and cohesin-binding site is located between TCRA locus and the neighboring housekeeping gene 
DAD1, functioning as an insulator, as the depletion of cohesin led to an increased transcription 
of DAD1144. Interaction between TCRA enhancer and Dad1 was shown to occur both in mouse 
T- and B-lymphocytes, although in the latter it was slightly weaker143,144. The conservation of 
TCRA locus in mouse and human145 implies a similar chromatin conformation in human 
lymphocytes with mouse. Expectedly, in our GM12878 ChIA-PET data, one anchor of the loop 
overlapped with TCRA enhancer, the other anchor is situated in Dad1 gene body (Figure 2.1B), 
which is similar to the observation in mouse T cells, suggesting the insulation function of our 
target loop in human cells, adding biological meaning to the study on its detailed folding 
conformation. 
To keep the integrity of the loop in consideration of staining efficiency, we extended 
10kb at both sides. Basically, we were investigating a 33kb chromatin region that contains an 
interaction loop inside that is shown in both chromatin interaction heat map (Figure 2.1A) and 
genome browser (Figure 2.1B). The surrounding epigenomic landscape of this region is shown in 
(Figure 2.2). By genomic modeling, we reconstructed the conformation of the target based on 
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sequencing data (Figure 2.1C). However, the chromatin structure inferred by population data 
lacks specificity and accuracy of individual cells or alleles, which led us to interrogate it by 
super-resolution imaging. Oligopaints probe46 for DNA FISH was designed to target on the 
chromatin specifically by avoiding DNA repeats region, resulting a staining density of about 10 
oligos/kb, allowing us to visualize the target chromatin as a dot by conventional microscope, 
though lacking details of the structuring. The composition of each probe oligo was shown in 
Figure 2.1D. 
Fine structures of target chromatin revealed by 3D super-resolution iPALM 
imaging 
We applied iPALM58 to samples labeled with Atto647N, achieving the resolution at 
single molecule level (Figure 2.1E). We acquired six good quality images of the target chromatin 
(Figure 2.1E) for following analysis. 
Briefly, samples were imaged at 30-50ms exposure, under 3kW/cm2 of 647nm laser 
excitation and 100W/cm2 405nm laser activation for 25,000 frames to capture blinking Atto 
647N molecules.  Data was imported into the PeakSelector software package (Janelia Research 
Campus), which registers each of the three camera images with respect to each other, calibrates 
the intensity across each camera as a function of z-position, and localizes each blinking molecule 
in 3D.  Further, fiducial nanoparticles embedded in the coverslip allow for drift correction after 
acquisition and localization to maximize image resolution. By pre-processing, localizations were 
filtered based on localization uncertainty in all three dimensions and data were rendered as 
3D .tif stacks or exported as vectorized datasets for further analysis. 
Each image (Figure 2.1E) shows a one copy of the 33 kb chromatin target. The well-
separated red spots represent single fluorescent molecules bound along the chromatin. From the 
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images, we can tell the spots are not randomly distributed but conformed in some order to build 
featured structure.  
 
  
chr14:22.7Mb – 24.05Mb
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Figure 2.1 Experimental design and acquired images 
(A) Representation of the target chromatin loop by Hi-C heatmap. The upper heatmap 
shows a larger view of the chromatin loop inside. The lower heatmap shows the exact 
target region for visualization, within which, the blue and green dots indicate RNAPII 
mediated and CTCF mediated chromatin loops, respectively, inferred by ChIA-PET.  
(B) Browser view of CFCF and RNAPII mediated chromatin loop of the target region. 
(C) Modeled chromatin structure using Hi-C and ChIA-PET data. 
(D) Probe design for DNA FISH and schematics of iPALM imaging. 
(E) Six acquired images for the distinct chromatin loop by iPALM. 
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Figure 2.2 Landscape of the chromatin loop 
The left panels are the browser views of ChIA-PET data for the chromatin loop and its 
surroundings. The middle panels are ChIA-PET heatmaps for the corresponding chromatin loop 
and surrounding regions. The right panels are Hi-C heatmaps for the corresponding regions. 
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Reconstruction of chromatin targets from iPALM images 
We modeled the chromatin structure by extracting and connecting all the spots in the 
images using different algorithms. All six images were analyzed to get confident single molecule 
spots from pre-processed images (Figure 2.3A). Basically, we extracted significant signals, 
measured brightness of images in relative luminosity units which range from 0 to 255. 
Brightness threshold was chosen manually to cut off noises. We then started from the lowest 
brightness level (threshold level) and increasing the value by ten in each step, until we reached 
maximum brightness of the image (Figure 2.4). In this way we examined different sets of spots 
of signals at each step, that allowed us to identify all spots desired. The number of spots varied 
between different images, ranging from 42 to 110 (Table 2.1), which is much smaller than the 
total number of probe oligos for each copy of chromatin target.  A couple of reasons can cause 
this under-stained effect: the chromatin cannot be ideally fully stained due to the FISH efficiency; 
some signals can get lost during data processing. We then characterized each image by spot 
count and volume, as well as the nearest distance between spots (Figure 2.3B, 2.3C, 2.5). The 
average dot count of each image is 68, and volume is 0.005 µm3 (Table 2.1). The nearest 
distance enriched in the spectrum of 0-60 nm. Intriguingly, each structure of the target looks 
different from another, indicating the heterogeneity of the genome across cells, at this higher-
order level. 
As there is no obvious way to determine the orientation of the target chromatin loop from 
the staining, we used three different algorithms to simulate and reconstruct the chromatin 
conformation. Each set of points was connected using NN, NJ and TSP algorithms (Figure 2.3D, 
E, F, G). The obtained structures were smoothed using cubic spline interpolation. Four simulated 
structures were generated for each image. We then measured the linear length of these modeled 
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structures (Table 2.2). Considering the probing density is in average of 10 fluorophore/kb, it is 
about able to resolve up to the lower level “beads on string” structure with around 150 bp per 
unit, even though the DNA is under-stained.  As previously reported, the first level of DNA 
compaction from base pair backbone to histone modified “beads on string” structure is about five 
to ten-fold condensation in size8. Therefore, our target 33 kb chromatin is estimated to be around 
2244 nm to 4488 nm by first level compaction. Compared with our modeled DNA length, most 
of them are within the estimated range, only two of the images have shorter length, which may 
suggest a truncated chromatin structure due to the limitation of imaging penetration depth.  
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Figure 2.3 Image characterization and modeling 
(A) Signal extraction from image 2. Each red spot indicates one fluorophore tagged with DNA 
probe oligos. 
(B) 3D volume of Image 2. 
(C) Distance distribution of the nearest spots in Image 2. 
(D) (E) (F) (G) Image modeling with different algorithms for Image 2. 
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Figure 2.4 iPALM image processing algorithm 
The upper panel is a schematic illustration to extract probe spots from pre-
precessed. The lower panel is a processing example of Image 2 
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Figure 2.5 Characterization of volumes and distances between spots for each image 
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Table 2.1 Characterization of images 
 
Table 2.2 Linear length of image models 
 
  
 
Image 1 Image 2 Image 3 Image 4 Image 5 Image 6 
Spot count 50 80 42 73 51 110 
Volume (nm3) 3,906,301 6,077,427 2,753,653 4,716,177 1,993,389 11,434,228 
  Linear length of the models for images (nm) 
Algorithm Image 1 Image 2 Image 3 Image 4 Image 5 Image 6 
NJ 2297.63 2569.35 3150.5 3481.72 1699.51 1897.23 2842.1 3218.16 1775.18 1967.29 4751.28 5346.97 
NN1 2143.24 2320.08 2420.73 2651.38 1428.13 1562.75 2621.51 3092.21 1589.24 1743.19 3581.4 3829.22 
NN2 1968.2 2119.16 2531.7 2730.49 1432.12 1606.68 2402.78 2592.97 1590.37 1742.47 3716.58 4013.24 
TSP 1848.5 2038.64 2422.66 2596.36 1267.72 1383.92 2238.86 2404.38 1312.37 1417.93 3364.43 3623.48 
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Correlation of physical coordinates with chromatin contact mapping data 
To assess the concordance between imaging and sequencing data, we analyzed the Hi-C 
data for the loop region. Based on the location of contact anchors we defined four contact 
categories: loop (with both anchors contained within the loop region), flank (with both anchors 
located in flank regions), loop-flank (with one anchor in loop region and the other in one of the 
flanks) and inter-flank (with anchors located in flanks on both sides of the loop) (Figure 2.6A). 
As expected, we noted that the interaction frequency of the contacts within loop or flank 
as seen in Hi-C heatmap was significantly higher than for the loop-flank and inter-flank (Figure 
2.6C, 7, 8, 9, 10, 11, 12). Considering this effect is to some extent due to higher frequency of 
contacts between regions located close to each other, we removed the shortest contacts from the 
analysis and observed very similar patterns. 
We also analyzed the relation between physical distance as measured in imaging-based 
structures between pairs of points and the frequency of contacts between the corresponding loci. 
We assumed that chromatin loops are highly flexible and that they can take different 
conformations across time and different cells. Thus, to identify the expected patterns and 
variability we used molecular dynamics simulations to model a number of toy regions with 
varying pattern of contacts. We modeled the loop region using a beads-on-a-string model with 
340 equidistant points. A random walk structure was used as the initial configuration. The 
simulation was run for 1000 steps, and the first 200 steps were discarded. Then we extracted 
every twentieth frame and analyzed them both individually and collectively. As a result, most of 
models has shorter distance in loop regions compared to the other three categories (Figure 2.7, 
2.8, 2.9, 2.10, 2.11, 2.12). The imaging models generally exhibited similar patterns, but there 
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was large variability between different methods and images. This suggests that the chromatin 
loops are very flexible and dynamic. 
For each model of the images we plotted the 3D distance between pairs of points against 
the contact frequency from the corresponding Hi-C heatmap bins and genomic distance between 
them (Figure 2.7, 2.8, 2.9, 2.10, 2.11, 2.12). In all the cases we observed that contacts 
representing different types are relatively well-separated. In general, loop-flank and inter-flank 
contacts are characterized by longer 3D distance and lower Hi-C frequency, whereas flank and 
loop contacts tend to have smaller distances and higher contact frequency. 
Looking back to all the models made from different algorithms, we found the NJ models 
are the least matched with the hypothesis that the loop region has the shortest pair-wise physical 
distances, while the NN models are the most matched, suggesting NN algorithm works the best 
in this structure modeling.  
  
 
A B C
Figure 2.6 Comparisons of image models with sequencing data 
(A) Schematics of the target chromatin loop inferred by ChIA-PET data. 
(B) The chromatin contact information characterized by 3D distance in different regions of the 
chromatin loop indicated in (A) for Image 2 modeled by nearest neighbor 1. 
(C) 3D scatter plot for chromatin contacts characterized by 3D distances in nearest neighbor1 
modeled Image 2 and Hi-C frequency data. 
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Figure 2.7 Comparisons of image models with sequencing data for Image 1 
The top panels are image models from different algorithms. The middle panels are 3D distance plot 
of the models. The bottom panels are the chromatin contact within the target region characterized 
by 3D distance and Hi-C frequency.  
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Figure 2.8 Comparisons of image models with sequencing data for Image 2 
The top panels are image models from different algorithms. The middle panels are 3D distance 
plot of the models. The bottom panels are the chromatin contact within the target region 
characterized by 3D distance and Hi-C frequency.  
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Figure 2.9 Comparisons of image models with sequencing data for Image 3 
The top panels are image models from different algorithms. The middle panels are 3D distance 
plot of the models. The bottom panels are the chromatin contact within the target region 
characterized by 3D distance and Hi-C frequency.  
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Figure 2.10 Comparisons of image models with sequencing data for Image 4 
The top panels are image models from different algorithms. The middle panels are 3D distance 
plot of the models. The bottom panels are the chromatin contact within the target region 
characterized by 3D distance and Hi-C frequency.  
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Figure 2.11 Comparisons of image models with sequencing data for Image 5 
The top panels are image models from different algorithms. The middle panels are 3D distance 
plot of the models. The bottom panels are the chromatin contact within the target region 
characterized by 3D distance and Hi-C frequency.  
Dissertation          Jacqueline Jufen Zhu 
 51 
  
   
Neighbor Joining Nearest Neighbor 1 Nearest Neighbor 2 Traveling Salesman
Figure 2.12 Comparisons of image models with sequencing data for Image 6 
The top panels are image models from different algorithms. The middle panels are 3D distance 
plot of the models. The bottom panels are the chromatin contact within the target region 
characterized by 3D distance and Hi-C frequency.  
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2.4 Discussion  
This is the first time a candidate chromatin loop is investigated and visualized using 
super-resolution microscope. Though we expected to see a major loop in the target chromatin 
region inferred by ChIA-PET data, we observed more complex looping structures in each 
individual image that differed from each other. There are a variety of possible reasons for the 
observation. 1. The chromatin loop could be heterogeneous between cells and even alleles, or 
dynamic other than static in different cell stages. The captured loop suggested by ChIA-PET data 
just indicated one possible conformation that occurred most frequently at that region. It does not 
mean other conformations could not happen as other types of conformations could be too rare to 
be captured. Our imaging data is not inclusive enough due to the limitation of the sample size to 
reflect the frequencies of each type of the looping incidences. 2. There are structures that cannot 
be captured by molecular strategies. Both ChIA-PET and Hi-C are based on a hypothesis that the 
chromatin interactions are mediated by protein factors. In other words, the chromatin that has no 
protein binding cannot be captured and modeled, though we cannot deny there are ultra-complex 
twisting and tangling for DNA packing in the nucleus. 
This study allows a direct visualization of the chromatin looping in a specific region that 
we clearly see the physical winding of DNA, though there are limitations hindering us from 
interpreting the observations more comprehensively. For instances, we are not able to exactly 
map the iPALM images to the corresponding genome coordinates; we have not got a chance to 
image the non-looping regions inferred by genome sequencing data; a larger sample size would 
be helpful bridging the gap of the comparisons between individual by imaging and population by 
sequencing. 
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The imaging data is more direct and straightforward for revealing chromatin 
conformation than the sequencing data. Therefore, the observations or findings that are not in or 
against our expectations from the sequencing data are not frustrating but even more suggestive to 
the current understanding the chromatin looping. 
As a pilot study, the experimental design could be further improved. As stated previously, 
we were not able to distinguish the chromatin loop region and extended tails of the loop by 
single color DNA FISH staining visualized by iPALM. In the future, dual color can be used to 
stain the loop and tails separately, increasing the accuracy of the conformation corresponding to 
the coordinates, decreasing the difficulties in the following modeling. To inclusively capture the 
possible chromatin structures and estimate the distribution of the occurrence frequencies, a larger 
sample size is needed. Furthermore, negative controls could be used for comparison, such as a 
non-looping region in the same cell line or the same target region with a non-looping structure in 
another cell line inferred by sequencing data. Besides the 13 kb chromatin loop at Chr14, it is 
interesting to investigate other chromatin loops at different length scales in different 
chromosomes. The fundamental principle of chromatin looping should be pursued. 
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Chapter 3 
3.1 Introduction 
Metastasis is often found in breast cancer, which is the major cause to mortality. 
However, the mechanism underlying is not clear. Studying the genome organization of cancer 
cells can reveal higher order regulatory mechanism of tumorigenesis and metastasis and in order 
to suggest clinical cure. Identification of these critical targets, however, has been challenging due 
to the complex nature of the metastatic process. In breast cancer, patients can survive for years, 
even decades, before the manifestation of metastatic disease146.  During the years between the 
diagnosis of the primary tumor and metastatic relapse, occult tumor cells have remained 
undetected until some currently undefined and unobserved event results in their conversion to a 
proliferative secondary tumor.  Since millions of cells can be shed by the primary tumor per 
day147 and dissemination can commence early in tumor evolution148,149, current hypotheses 
suggest that the colonization step - the conversion from quiescent to actively growing tumor cells 
- is likely the rate-limiting step in the metastatic cascade.  However, as indicated above, the 
quiescent-to-proliferative switch can occur anytime over a period of years to decades. This, 
coupled with the estimate that less than 1 in 10,000 tumor cells is likely to make the 
conversion150, makes direct visualization of the mechanisms and pathways involved very 
challenging, even within model organisms. 
Results from genomic studies indicate genome organization within the nucleus is 
nonrandom, which suggests important functions in gene expression151,152. Higher-order genome 
structure such as chromosome territory reorganization and gene repositioning were found to be 
associated with human diseases and cancers17,96,153,154. More recently, studies showed genome 
architecture mediate interactions between regulatory elements such as enhancers and gene 
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promoters to allow delicate gene regulation31,106,109,155. However, since genomic distance is not 
always consistent with physical distance in vivo, linear arrangement of the genome cannot fully 
represent the mechanism responsible for transcription regulation. Techniques that combine 
biochemistry with high-throughput sequencing such as Hi-C and ChIA-PET have been used to 
genome-widely map long-range chromatin interactions. Bound by transcription factor complexes, 
enhancers can be brought proximal to promoters to enhance gene transcription. Disruption of 
these 3D structures can lead to enhancer malfunction resulting in inappropriate gene expression, 
potentially leading to diseases and cancers73,86. It has been reported that disease-associated 
variation is especially enriched in enhancers of disease-relevant cell types, and cancer cells 
generate enhancers at oncogenes and other genes important in tumor pathogenesis109,156. Hence, 
higher-order chromatin conformation could be a critical driver in breast cancer metastasis.  
CRISPR-based technology validated the importance of one set of enhancer-promoter 
interactions on target gene expression.  Moreover, the analysis has been broadened to include 
five genetically related but metastatically divergent strain pairs which allows the identification of 
a core set of common metastasis susceptibility genes and molecular pathways.  The results of 
these studies implicated inherited variation in metabolic pathways as important common 
mediators of metastatic progression.  Furthermore, pre-existing therapeutics are implicated as 
either potential pro- or anti-metastatic agents that might be used or avoided to reduce subsequent 
metastatic burden.  These studies therefore provide novel insights into a potential core set of 
processes associated with breast cancer progression that might be exploited to reduce the burden 
and mortality of breast cancer metastatic disease, as well as important insights into the epigenetic 
regulation of metastatic progression.  
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3.2 Materials and Methods 
Cell Lines 
4T1, 4T07 and 67NR30 were obtained from the laboratory of Lalage Wakefield (NCI) and 
confirmed to be of BALB/c mouse origin by microsatellite genotyping.  All cell lines were 
mycoplasma-free. 
Benzonase accessible chromatin (BACh) sequencing analysis 
Cells were expanded in DMEM with 10% FBS and P/S at 37°C to obtain 8–10 x107 
cells/condition/each experiment. BACh analysis was performed as previously described with 
minor modifications157. Briefly, cells were collected by centrifugation, washed twice in ice cold 
cellular wash buffer (20 mM TrisHCl pH 7.5, 137 mM NaCl, 1 mM EDTA , 10 mM sodium 
butyrate, 10 mM sodium orthovanadate, 2 mM sodium fluoride, protease inhibitor cocktail 
(Roche)) and resuspended in (40 million cells/ml) hypertonic lysis buffer (20 mM TrisHCl pH 
7.5, 2 mM EDTA, 1 mM EGTA, 0.5% glycerol, 20 mM sodium butyrate, 2 mM sodium 
orthovanadate, 4 mM sodium fluoride, protease inhibitor cocktail (Roche)). Cells were 
distributed in 500µl aliquots in 1.5 ml tubes and followed by the addition of 500µl of nuclease 
digestion buffer (40 mM TrisHCl pH 8.0, 6 mM MgCl2, 0.3% NP-40, 1% Glycerol) containing a 
3-fold dilution (from 0.125 units/ml to 6U units/ml) of Benzonase (Calbiochem/EMD). This was 
mixed gently and incubated for three minutes at 37°C. Reactions were terminated by the addition 
of EDTA (10 mM final) and SDS (0.75% final). Proteinase K was added to a final concentration 
of 0.5 mg/ml and incubated overnight at 45°C. DNA fragments of 100-500 bp from a chromatin 
digestion were purified over sucrose gradients158 and precipitated in 0.1 volume NaAc and 0.7 
volume isopropanol. 
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Sequencing and data analysis of Benzonase-treated samples 
DNA was sequenced using either Illumina HiSeq2000 (TrueSeq V3 chemistry) or NextSeq500 
(TrueSeq High output V2 chemistry) sequencers at the Advanced Technology Research Facility 
(ATRF), National Cancer Institute (NCI-Frederick, MD, USA).  The sequence reads were 
generated as either 50-mer or 75-mer (trimmed to 50-mer by trimmomatic software before 
alignment), and tags are then aligned to the UCSC mm9 reference genome assembly using Eland 
or Bowtie2. All the samples had good quality with over 94% of the bases having Q30 or above 
with 25~50 million raw reads per sample. Regions of enriched tags termed hotspots have been 
called using DNase2Hotspots algorithm159  (http://sourceforge.net/projects/dnase2hotspots) with 
FDR of 0% with minor updates. Tag density values were normalized to 10 million reads. For 
comparison of BACh profiles across multiple cell lines, percent reference peak coverage (PRC) 
measure was proposed and employed to ensure compatible levels of digestion by Benzonase in 
multiple cell lines. To calibrate PRC, commonly represented hotspot sites were identified as 
reference peaks based on mouse (mm9) DNaseq data from ENCODE. ENCODE narrowPeak 
definition files (DNaseI Hypersensitivity by Digital DNaseI from ENCODE/University of 
Washington) for a total of 133 samples were downloaded from the UCSC golden path web site: 
http://hgdownload.cse.ucsc.edu/goldenPath/mm9/encodeDCC/wgEncodeUwDnase/. A total of 
8,587 peaks were found to be present in all 133 samples. By assuming that the most commonly 
accessible sites may also be present in our optimally digested samples, PRC was obtained as a 
fraction of reference peaks presented in each sample to evaluate the level of digestion by 
Benzonase. Two biological replicates with acceptable PRC were selected and pooled for each 
cell line. When samples showed bimodality in their tag density distribution due to elevated noise, 
we dropped hotspots that belonged to a group with low tag density and low PRC by applying 
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threshold to maximum hotspot tag density values. Each hotspot was classified in relation to 
genomic features, promoter, exon, intron, distal upstream and downstream classes, based on the 
annotation information on refGene.txt downloaded from 
http://hgdownload.cse.ucsc.edu/goldenpath/mm9/database/. The classification of each BACh was 
used to generate lineage plots for different BACh categories. Comparison of the relative position 
of the retained versus lost BACh were shown by plotting empirical cumulative distribution 
(ECDF) of the absolute distance to nearest transcription start site (TSS) from the mid-point of a 
hotspot from two groups of BACh: BACh lost, (67NR, 4T07, 4T1) : (+, -, -) or (+, +, -), and 
BACh retained, (67NR, 4T07, 4T1) : (+, +, +), as malignancy increases. The two distributions 
were compared by two sample Kolmogorov-Smirnov test (K-S test)159.  
Long Read ChIA-PET and data processing 
Long read ChIA-PET was performed using Tn5 transposase to tag DNA for long tag sequencing 
by Illumina Nextseq. ChIA-PET data was processed by a customized ChIA-PET data processing 
pipeline54.  Detailed protocol can be found in the paper “Long-read ChIA-PET for base-pair 
resolution mapping of haplotype-specific chromatin interactions”160. 
RNA-seq data analysis 
DESeq2 was used to analyze the RNA-seq data for 4T1, 4T07 and 67NR cells to identify 
differentially expressed genes. The cut-off used was 3-fold change of normalized gene 
expression (baseMean), Padj < 0.01. By pair-wise comparison, over-expressed genes were 
identified for each cell line compared to the other two cell lines.  
Cell line specific enhancer identification 
Based on identified over-expressed gene in 4T1, 4T07 and 67NR and RNAPII-mediated 
chromatin interactions, genomic loci (promoter region excluded) that distantly interact with the 
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gene promoters that have RNAPII binding peaks were filtered out as candidate enhancers. By 
comparative analysis and subtractive strategy, the enhancers that specifically occurs in each cell 
line but not overlap with any other regulatory elements interacting with promoters in the other 
cell lines were further identified as cell line specific enhancers.   
Fosb knockdown 
DsiRNA for Fosb was designed and produced by IDT with sequence1: 
rArCrArArUrCrUrArUrArUrCrGrUrUrGrArGrArArUrUrCTG and sequence2: 
rCrArGrArArUrUrCrUrCrArArCrGrArUrArUrArGrArUrUrGrUrArA. Cells were transfected 
using Lipofectamine RNAiMAX and then incubated for 72h for harvest (ThermoFisher 
Scientific).  
CldnE knockout experiment 
Cas9 transgene was first introduced by infecting cells with lentivirus derived from plasmid 
lentiCas9-Blast (gift from Feng Zhang; Addgene plasmid # 52962), followed by Blasticidin 
selection, creating the 4T1_Cas9 cell lines. Then two plasmids expressing guides targeting 
upstream (guide sequence: GAGTGAGTTCTCAGACAGCCA) and downstream (guide 
sequence: GGTGTCTGTCCTTTACAGCA) of the CldnE were co-transfected with three knock-
in/knock-out plasmids each carrying an EF1a promoter driven antibiotic resistance gene casette 
(Hygro, Puro, Neo) flanked by 1kb homology arms upstream and downstream of the CldnE 
deletion region, into the Cas9-expressing 4T1_Cas9 cells. To select for multiple allelic 
knockouts, cells were selected simultaneously with hygromycin, puromycin, and geneticin. 
Single clone knockout was isolated by flow cytometry and genotyped by PCR and Sanger 
sequencing. Primers for genotyping can be found in Table 3.1.  
Table 3.1 Primers for genotyping 
Name Sequence 
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CldnE_mutant F CGGAACTTCAGTTGACTGCCTC 
CldnE_mutant R ctgtgttctggcggcaaacc 
CldnE_wildtype F CGGAACTTCAGTTGACTGCCTC 
CldnE_wildtype R CTATTGCAGGCTCAGGGCTAATC 
 
qRT-PCR 
Gene expression of CldnE knockouts was measured by qRT-PCR. Primers are attached in Table 
3.2.  
Western blot 
Three CldnE knockout strains and 4T1_Cas9 as control were used in this assay. The experiment 
was done following the general protocol from BIO-RAD. The gel image was analyzed using FIJI 
to quantify the protein expression by measuring the raw intensity of the protein bands.  
Wound healing and cell migration assay 
Three CldnE knockout strains and 4T1_Cas9 as control were used in this assay. Culture dish 
with silicone insert were purchased from Ibidi (Cat. # 80206). The same number of cells for each 
strain was seeded in the inserts and after 24 hours culture a monolayer of cells and a defined 500 
um cell free gap was formed. Images of the gap were captured every two hours till eight hours 
with 10x objective of a widefield microscope (Leica DMi8). Size of the gaps at each time point 
was measured using FIJI. The cell migration speed was calculated with a linear trend.   
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Table 3.2 Primers for qRT-PCR 
Name Sequence 
Actb F CTCTGGCTCCTAGCACCATGAAGA 
Actb R GTAAAACGCAGCTCAGTAACAGTCCG 
Cldn3 F ACCAACTGCGTACAAGACGAG 
Cldn3 R CAGAGCCGCCAACAGGAAA 
Cldn4 F GTCCTGGGAATCTCCTTGGC 
Cldn4 R TCTGTGCCGTGACGATGTTG 
Abhd11 F ACTCCCAAGCCCGAAAAC 
Abhd11 R CGTATCCAAGTTCAGTCTCCAG 
Fosb F AGGCAGAGCTGGAGTCGGAGAT 
Fosb R GCCGAGGACTTGAACTTCACTCG 
Cdh1 F CACCTGGAGAGAGGCCATGT 
Cdh1 R TGGGAAACATGAGCAGCTCT 
Wnt7a F TGAAGAGGACCCAGTGACAGG 
Wnt7a R GGCGTACTGGTGTGTGTTGT 
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3.3 Results 
Identification of metastasis-associated genes and their regulatory elements and 
factors in 4T1 cell line series 
The tumors from these three cell lines - 67NR, 4T07 and 4T1 - span the malignant 
spectrum when inoculated into the mammary fat pad of BALB/c mice, with 67NR remaining 
localized, 4T07 disseminating to and remaining as single cells in the lung, and 4T1 forming 
macroscopic pulmonary metastatic lesions. In order to examine the transcription associated with 
metastasis, we performed RNA-seq with 4T1 cell series and identified 743, 620 and 968 up-
regulated genes in 4T1, 4T07 and 67NR, respectively, by comparative analysis (Figure 3.1A). 
4T1 up-regulated genes were specifically enriched in tight junction and lipid biosynthesis (Figure 
3.1B). Though tight junction usually is thought as a key component of maintaining cell adhesion 
and tissue integrity to suppress metastasis of invasive tumor cells161,162, in 4T1 cell model, the 
activated or enhanced expression of tight junction genes including Cdh1, Cldn3 and Cldn4 might 
function to facilitate the cell colonization instead of building a barrier for secondary tumor 
formation. In addition, many other 4T1 up-regulated genes identified here such as Wnt7a, Il1a 
and Hoxa cluster have also been reported previously to be related to cancer metastasis163–167.  
To answer the question how these metastasis-associated genes were regulated in the 
perspective of higher-order genome organization, we analyzed the RNAPII ChIA-PET data to 
characterize chromatin interactions with both anchors located at BACh to identify cell line 
specific enhancers that were interacting with these genes. Specifically, 261 cell specific 
enhancers were identified to connect with 175 colonization-associated genes and 567 cell 
specific enhancers were interacting with 265 colonization suppressing-associated genes in 4T1 
and 67NR, respectively. By analyzing this subset of enhancers and their targeting gene 
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promoters, we found differential enrichment of protein-binding motifs at gene promoter and 
enhancer region for both classes of genes (Figure 3.1C, Figure 3.2B). Enhancer region were 
enriched for Fos:Jun (AP-1) family protein binding, while gene promoter region were mainly 
enriched for Sp1 family protein. AP-1 family is known as important protein factors that are 
crucial for human breast cancer metastasis168–170, but the regulation via enhancers hasn’t been 
stated yet. Therefore, our study suggested its bidirectional role in regulating metastasis, that is, it 
could either promote or attenuate metastasis progression in different cell lines.  
To validate Fos:Jun family protein functions in regulating colonization-associated genes 
in 4T1 cells, we performed RNAi to knock down a 4T1 up-regulated gene Fosb. The gene 
expression of candidate targets that have Fos:Jun binding motif at their enhancer region (Figure 
3.2A) were examined by qRT-PCR in Fosb knockdown cells where Fosb was down-regulated 
about three fold (Figure 3.1D). Cldn3 and Cdh1 expression were observed to significantly 
decrease, while Cldn4 and Wnt7a remained at the same expression level (Figure 3.1D) that might 
be due to the binding of other Fos:Jun family proteins instead of Fosb. This result added 
evidences to prove that Fos:Jun family protein regulate colonization-associated genes by binding 
at enhancer sites.  
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Figure 3.1 Characterization of cell up-regulated genes and associated enhancers in 4T1, 4T07 
and 67NR 
(A) Heap map shows the differentially expressed genes in 4T1, 4T07 and 67NR cells. By 
comparing gene expression between cell lines using DESeq2, the conditions of defining gene 
upregulation are log
2
(fold change) > 1.5, FDR < 0.01. Red color indicates upregulation. Blue color 
indicates downregulation.  
(B) The enriched functions by gene ontology analysis of cell line up-regulated genes are shown 
with FRD (left side) and fold enrichment (right side).  
(C) Motif analysis was done with 276 identified BACh sites located within enhancer region as well 
as their interacting promoters of 175 in 4T1 cells. The enhancers are enriched for Fos:Jun protein 
family binding, while the promoters are enriched for SP1 family binding. Specifically, 59 enhancer 
sites are found to have Fos:Jun binding motif and 60 sites have SP1 binding motif.  
(D) Gene expression level was measured in Fosb knock-down cells. Metastasis-associated genes 
Cldn3 and Cdh1 were significantly down-regulated in Fosb knock-down cells by RNAi.  
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Figure 3.2 Binding motif analysis 
(A) Examples of BACh sites located within enhancers that interact with metastasis-associated genes 
and have Fos:Jun binding motif. Red color indicate Fos:Jun binding motif sequence. 
(B) Motif analysis was done with 591 identified BACh sites located within enhancer region as well 
as their interacting promoters of 265 in 67NR cells. The enhancers are enriched for Fos:Jun protein 
family binding, while the promoters are enriched for SP1 family binding. Specifically, 143 BACh 
sites are found to have Fos:Jun binding motif and 69 sites have SP1 binding motif.  
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Gain or loss of functions of metastasis-associated genes by enhancer regulation 
Enhancer interaction not only implicated important roles of certain transcription factors, 
but also suggested an accurate regulatory mechanism of metastasis-associated genes. Some of 
the identified genes were connected with more than one enhancer (Figure 3.3A, 3.4A, Table 3.3 
and Table 3.4), building up a delicate and complex regulation system, which further implied their 
importance in metastasis. For instance, Wnt7a was observed to be involved in a variety of 
cancers171–173. In 4T1 cells, Wnt7a was found to promote breast tumor invasion and metastasis 
via potentiating TGFb receptor signaling163. Comparatively, our study revealed Wnt7a promoter 
was connecting to three potential enhancers located 20kb to 130kb away, either within gene body 
or at non-coding region (Figure 3.3B). Another example comes in 67NR cells. A chemokine 
gene Ccl7 that is broadly studied and reported to be associated with cancer progression174,175 was 
highly expressed in 67NR cells, while had no expression in 4T1 cells. Within a 200 kb region, 
Ccl7 promoter was interacting with eight enhancers that were only present in 67NR cells (Figure 
3.4B). The gain or loss of enhancers would be one of the reasons for gain or loss of function of 
metastasis associated genes.   
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Figure 3.3 Characterization of 4T1-specific enhancers 
(A) Enhancer distribution per gene in 4T1 cells was characterized. 261 identified enhancers are 
connecting with 175 up-regulated genes. Most of the genes are interacting with one enhancer, but 
the others interact with multiple enhancers.  
(B) The example shows a gene interacting with multiple enhancers. 4T1-upregulated gene Wnt7a 
is observed to interact with three enhancers. Green line indicates Wnt7a gene promoter site. Red 
lines indicate enhancer sites.  
(C) Gene distribution per enhancer in 4T1 cells is characterized. Most of the enhancers are 
connecting with only one 4T1-upregulated gene, but 12 of them are interacting with two identified 
genes and the other one is interacting with four genes.  
(D) The example shows an enhancer interacting with multiple genes. An enhancer is interacting 
with Cldn3, Cldn4 and Abdh11 directly. Cldn3 and Cldn4 are only expressed in 4T1 cells 
compared to 4T07 and 67NR. Though Abhd11 is not that significantly up-regulated in 4T1, 
decreased expression can be observed in 4T07 and 67NR. Green line indicates gene promoter sites. 
Red line indicates the enhancer.  
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Figure 3.4 Characterization of 67NR-specific enhancers 
(A) Enhancer distribution per gene in 67NR cells is characterized. 567 identified enhancers are 
connecting with 265 up-regulated genes. Most of the genes are interacting with one enhancer, but 
the others interact with multiple enhancers.  
(B) The example shows a gene interacting with multiple enhancers. 67NR-upregulated gene Ccl7 is 
interacting with eight enhancers. Green line indicates Ccl7 gene promoter site. Red lines indicate 
enhancer sites.  
(C) Gene distribution per enhancer in 67NR cells is characterized. Most of the enhancers are 
connecting with only one 67NR-upregulated gene, but 29 of them are interacting with two 
identified genes.  
(D) The example shows an enhancer interacting with multiple genes. An enhancer is interacting 
with Mdm2 and Rab1b directly. Mdm2 and Rab1b are significantly up-regulated in 67NR cells 
compared to 4T1 and 4T07. Green line indicates gene promoter sites. Red line indicates the 
enhancer.  
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Table 3.3 Multiple enhancer regulation on metastasis-associated genes in 4T1 cells 
Gene Symbol Enhancer Count Gene Symbol Enhancer Count 
Hes1 6 Fbln2 2 
Cdh1 4 Gm14023 2 
Endod1 4 Gm14207 2 
Krt8 4 Gm15051 2 
5430407P10Rik 3 Has2 2 
Bdh1 3 Has2as 2 
Cd24a 3 Hs3st1 2 
Cgnl1 3 Inhba 2 
Cldn4 3 Itga2 2 
Cnnm4 3 K230010J24Rik 2 
Epcam 3 Krt80 2 
Filip1l 3 Lamc2 2 
Gm16046 3 Lrp10 2 
Pdgfb 3 Myo1d 2 
Rbm47 3 Nuak2 2 
Ripk4 3 Phldb2 2 
Sorbs2 3 Plekha2 2 
Tmprss11e 3 Pmepa1 2 
Unc5b 3 Rin3 2 
Wnt10a 3 Rnpep 2 
Wnt7a 3 Sdc1 2 
2010204K13Rik 2 Sema3f 2 
5830416P10Rik 2 Susd1 2 
Bhlhe40 2 Tmem51 2 
Cldn3 2 Tnfaip3 2 
Ctgf 2 Tuba4a 2 
Dll4 2 Ubtd2 2 
Dnaja4 2 Vegfc 2 
Dock5 2 Wwc2 2 
Epha1 2   
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Table 3.4 Multiple enhancer regulation on metastasis-associated genes in 67NR cells 
Gene Symbol Enhancer Count Gene Symbol 
Enhancer 
Count Gene Symbol 
Enhancer 
Count 
Plk2 16 Adm 3 Dnhd1 2 
Ereg 10 Adrb2 3 Dysfip1 2 
Gdnf 10 Amacr 3 Eml1 2 
Jun 8 Ankrd57 3 Fam71f1 2 
B430305J03Rik 8 Apcdd1 3 Fhl4 2 
Ccl7 8 Aqp5 3 Foxd1 2 
Pde2a 8 Atf1 3 Gm12981 2 
2810474O19Rik 7 Csf1 3 Gm15608 2 
Fgfr1 6 Dclk1 3 Gm17249 2 
Gas1 6 Dhx29 3 Gm17443 2 
2900052L18Rik 5 Fgf2 3 Gm2115 2 
Bahcc1 5 Glipr1 3 Gpc4 2 
Cdkn2a 5 Gm12824 3 Gpx8 2 
Mex3b 5 Gm16508 3 Gypc 2 
Sparc 5 Gm9949 3 Irx1 2 
Xdh 5 Hrh1 3 Irx5 2 
1700023H06Rik 4 Itga7 3 Kcnh1 2 
A830082K12Rik 4 Kcnj2 3 Kitl 2 
Abcb1b 4 Msx2 3 Layn 2 
B230206L02Rik 4 Nt5dc3 3 Marcks 2 
Cadm1 4 Osbpl5 3 Mrgprf 2 
Cav1 4 Pak1 3 Naip2 2 
Ccdc109b 4 Pcdh7 3 Nrg1 2 
Chst1 4 Pik3r5 3 Pdpn 2 
Dcun1d3 4 Pmp22 3 Plcl1 2 
Dnajb4 4 Ppap2a 3 Prss42 2 
Ecm1 4 Rap1b 3 Ptgs1 2 
Gm11216 4 Rrm2b 3 Qrfp 2 
Gm12056 4 S100a7a 3 Rab30 2 
Gm9958 4 Sbno2 3 Rnf11 2 
Id2 4 Tbx3 3 Rusc2 2 
Lrrk2 4 Thbd 3 Sema5a 2 
Lyrm1 4 Tmem74 3 Sesn2 2 
Ndst3 4 Tspan17 3 Siglecg 2 
Otud1 4 Zbtb20 3 Snora2b 2 
Prrx1 4 1700012B09Rik 2 Snord123 2 
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Rgs2 4 9130023H24Rik 2 Tgfb1i1 2 
Snai2 4 A430110N23Rik 2 Tgfbr3 2 
1600021P15Rik 3 A930001C03Rik 2 Tigd5 2 
1700086P04Rik 3 Aen 2 Tmem45a 2 
2610037D02Rik 3 Ankrd55 2 Tusc1 2 
4632434I11Rik 3 Ap3b2 2 Usp14 2 
9230114K14Rik 3 Atp13a4 2 Vgll3 2 
Abca4 3 Cpne2 2 Zfpm2 2 
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Multitasking-enhancers regulate more than one metastasis-associated gene 
In addition to multiple enhancers being associated with a single gene, enhancers were 
identified that interacted and potentially regulated multiple metastasis-associated genes. In this 
study, we identified 13 and 29 multitasking-enhancers in 4T1 and 67NR cells, respectively 
(Figure 3.3C, Figure 3.4C, Table 3.5, Table 3.6). Multitasking-enhancers are expected to be 
more powerful than single-tasking enhancers, since they have the potential to regulate 
metastasis-associated genes and pathways in a more efficient manner. Figure 3.3D and Figure 
3.4D show examples of multitasking enhancers in 4T1 and 67NR.  
Claudin are the most important component of cell tight junction, which stand out in 4T1 
cells by gene ontology analysis. They are known to associate to breast tumor malignancy176–181. 
By comparison, Cldn3 and Cldn4 were highly expressed in 4T1 cells, while no expression was 
detected in 4T07 and 67NR cells. A multitasking-enhancer was identified and named as CldnE 
interacting with Cldn3 and Cldn4 genes, as well as an abhydrolase gene Abhd11 in 4T1 cells 
(Figure 3.3D), suggesting its important role in metastasis regulation. To interrogate whether the 
onco-enhancer is functional other than only structural, we implemented CRISPR/Cas9 to knock 
out the target enhancer CldnE (chr5: 135441137-135443563). Before knocking out, we prepared 
a 4T1_Cas9 cell line by lentivirus infection on 4T1 to constitutively express Cas9 protein. Then 
we transfected 4T1_Cas9 cells to replace CldnE with drug-resistant genes by homology-directed 
repair (HDR) (Figure 3.5A) for following knockouts selection. Considering the aneuploidy of 
4T1 cells, we designed three different drug-resistant gene donors for HDR to guarantee at least 
three copies of CldnE were simultaneously knocked out in a single 4T1_Cas9 cell by drug 
selection. When we got a puromycin-, geneticin- and hygromycin-resistant knockout cell 
population, flow cytometry was applied to sort them into single cells. We then randomly picked 
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ten single cell colonies that were genotyped (Figure 3.6A, 3.6B) to have interrupted CldnE for 
transcription quantification. Expectedly, by qRT-PCR, we observed a dramatic decrease of the 
target gene expression (Figure 3.5B), validated the regulatory function of multitasking-enhancer 
CldnE. We also performed Western blot to investigate the protein expression of Cldn3 and Cldn4 
in three single cell CldnE knockout clones. Compared with the control cells, one of clones had 
Cldn3 and Cldn4 protein dramatically down-regulated; the other two clones also showed 
decreased expression though not that significant except P1C10 expressed about the same level of 
Cldn4 with wildtype cells (Figure 3.6C). The statistics showed us Cldn3 protein was 
significantly down-regulated to 0.6-fold of the control and Cldn4 was about 0.8 fold. 
Furthermore, to examine if metastasis potential has been changed within these CldnE knockouts, 
we performed wound healing assay, which showed the knockouts migrated significantly slower 
than the control (Figure 3.5C, 3.5D), without observing a significant difference in cell 
proliferation. In addition, mouse implantation was conducted by injecting CldnE knockouts or 
control cells into nude mice. 30 incidences in lung (ten incidences for each cell line) were 
observed to count for micrometastasis in two CldnE knockouts and one control cell line. The 
micrometastasis is defined as metastatic seeds that have not yet development into visible 
macrometastatic tumors but can be observed as speckles. Though no significant difference was 
seen in macrometastatic pulmonary tumors (Figure 3.6D), micrometastasis was observed by 
H&E staining significantly less frequently occurred (P-value = 0.02235) in CldnE knockouts 
(Figure 3.5E). Therefore, we proved the pivotal role of Cldn3, Cldn4 genes and provided insights 
into the potential therapeutics in cancer metastasis by targeting on enhancers.  
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Figure 3.5 Functional validation of CldnE knockout by CRISPR 
(A) The schematic shows CRISPR knock-out strategy. HDR are introduced to both sides of the 
CldnE enhancer region. Three different antibiotics are knocked in when enhancers are knocked out 
to increase the probability of enhancer knock-out at more than three alleles in single cell by further 
antibiotics selection.  
(B) qPCR is done to measure the target gene expression in control and ten single cell clone CldnE 
knockouts. Cldn3, Cldn4 and Abhd11 are all significantly down-regulated in the knockouts. “*” 
indicates P-value is less than 0.05 by t-test.  
(C-D) Wound healing and cell migration assay. (C) Three single cell clone knockouts are selected 
for wound healing and cell migration assay. Images were taken every two hours till eight hours 
from the start. Here only 0-, 4- and 8-hour images are shown. Compared with control cells, 
knockout cells are observed to migrate slower. (D) Migration speed is calculated based on the 
measurement from the images. The control cells migrate at the speed of 116 μm/h, while knockouts 
migrate at 62 μm/h. (E) Micrometastasis was counted in knockouts and control cells. Ten 
incidences were observed for each cell lines. One incidence is one speckle observed in H&E 
staining. 
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Table 3.5 Multi-tasking enhancers in 4T1 cells 
Enhancer Coordinate Gene Count 
chr6:52023797-52028187 4 
chr12:103004008-103005806 2 
chr12:82719533-82721279 2 
chr14:56342201-56344158 2 
chr15:37049761-37051327 2 
chr15:56552071-56554508 2 
chr15:56672483-56673912 2 
chr2:119136894-119138322 2 
chr2:119139504-119140698 2 
chr2:129236520-129240516 2 
chr5:135430733-135444258 2 
chr7:141450421-141454102 2 
chr9:110582929-110584694 2 
 
  
Figure 3.6 Characterization of CldnE knockouts 
(A) Gel picture shows CldnE wildtype and knock-out DNA fragments. The upper bands indicate 
CldnE knockout genotype, which only shows up in the ten single cell clone knockouts but not in 
control. The lower bands indicate CldnE wildtype genotype, which shows up in all the samples, 
suggesting CldnE knock-out is not complete in the ten knockout cells.  
(B) CldnE knockout genotype is sequenced. The sequence spans the EF1α promoter in the 
targeting constructs to CldnE flanking region.  
(C) The upper panel shows Western Blot result of Cldn3, Cldn4 and Gapdh in 4T1_Cas cells and 
CldnE knockouts. The raw intensities of protein bands are measured using FIJI. Normalized by 
Gapdh, Cldn3 and Cldn4 expressed in CldnE knockouts are compared with 4T1_Cas9. The 
number underlying each band indicates the relative intensity of the band. The lower panel shows 
the statistics of Cldn3 and Cldn4 protein level in CldnE knockouts.  
(D) Primary, pulmonary metastatic tumor weight were measured in mouse implanted with 
knockouts and controls. Normalized metastasis was calculated. 
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Table 3.6 Multi-tasking enhancers in 67NR cells 
Enhancer Coordinate Gene Count 
chr10:117303670-117305698 2 
chr11:120113330-120115578 2 
chr11:120165218-120167654 2 
chr11:120167679-120170193 2 
chr11:120176495-120179043 2 
chr11:120213812-120216549 2 
chr13:113650957-113653080 2 
chr13:113991211-113994366 2 
chr14:31716840-31718849 2 
chr15:32251683-32253349 2 
chr15:32444308-32445350 2 
chr18:62209005-62211249 2 
chr18:62321109-62323590 2 
chr18:62362078-62364487 2 
chr3:32407170-32410547 2 
chr4:132000670-132003197 2 
chr4:140982579-140984296 2 
chr4:95527757-95529526 2 
chr5:18422249-18423650 2 
chr7:127030594-127032230 2 
chr7:127104239-127105575 2 
chr7:127240748-127242263 2 
chr7:135487713-135489437 2 
chr7:87274020-87276902 2 
chr7:99863142-99865504 2 
chr7:99980076-99982095 2 
chr8:33211357-33212580 2 
chr8:33310000-33311769 2 
chr9:110683374-110685628 2 
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3.4 Discussion 
Though the epithelial to mesenchymal transition is usually considered as a marker of 
metastasis, 4T1 mouse cell model showed a totally different mechanism. Metastatic 4T1 cell has 
more epithelial features while non-metastatic 67NR is more likely to be in mesenchymal stage. 
This phenomenon demonstrates the mesenchymal features are not always the markers or drivers 
for metastasis. Though theoretically, the mesenchymal cells are more likely to metastasize, other 
steps of metastasis can also be crucial such as colonization. 4T1 cells have tighter cell junction, 
likely to circulate in colony and colonize to the secondary tumor site more easily than 67NR cells.  
It is interesting that Fos:Jun was found to be involved in enhancer regulation in both 
metastatic and non-metastatic cells. It is hard to know if the same Fos:Jun proteins function 
oppositely in different cells or different Fos:Jun proteins take care of different metastatic 
potentials.  
 Enhancer has been well studied to regulate genes and associate with diseases. However, 
multitasking enhancer regulating cancer development is rarely studied. These powerful 
enhancers could be the potential targets for therapeutics. 
 By analyzing chromatin interactions between DNA elements and gene promoters, we 
should be able to identify other regulatory elements such as silencers and insulators besides 
enhancers. Enhancers are well-studied and found to play important roles in activating or 
enhancing gene transcription. While, we know relatively little about silencers, which functions in 
the opposite to enhancers, silencing or weakening gene transcription. Insulators work to insulate 
certain connections between gene and regulatory elements or between different chromatin 
domains. Genome architectural proteins such CTCF and cohesin are often seen to bind with 
insulators to cooperate insulation. For examples, the boundaries of TADs or insulated 
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neighborhood domains function as insulators to regulate transcription. Therefore, CTCF ChIA-
PET could be used to examine insulator distribution. Similar to enhancer analysis, comparative 
analysis of chromatin interactions in 4T1 cell line series could identify metastasis-associated 
silencers and insulators or chromatin domains that participate in metastasis progression. 
 I mainly focused on intra-chromosomal chromatin interactions in this thesis. However, 
inter-chromosomal interactions also exist and play important roles in genome organization and 
cellular function. To more comprehensively understand the associations of chromatin 
organization and gene transcription, inter-chromosomal interactions between promoters and 
regulatory elements should not be ignored. Preliminarily, I have observed interactions between 
metastasis-associated genes and multi-tasking enhancers inter-chromosomally by DNA FISH 
(Figure 3.7A, Table 3.7). In metastatic 4T1 cells, the co-localization frequency of a distinct Myc 
enhancer (named MycE) and other metastasis associated genes in different chromosomes is 
significantly higher than in non-metastatic 67NR cells and normal NIH3T3 cells (Table 3.7) as 
well as controls in 4T1, whereas the differences of co-localization frequency between target pairs 
and controls in 67NR is not as significant as in 4T1 (Table 3.7), indicating an involvement of 
MycE in regulating metastasis associated genes in trans in metastatic cells. Furthermore, we have 
validated the function of MycE by CRISPR knockout. In MycE knockouts, metastasis associated 
genes such as Cldn3, Cldn4, Cdh1 and Wnt7a were significantly down-regulated as well as Myc 
(Figure 3.7B). Considering Myc may have influences on other genes, we overexpressed Myc in 
MycE knockouts (Figure 3.7C) and measured the expression of candidate MycE regulating genes 
again. The results showed Cdh1 expression was not rescued in Myc overexpressed MycE 
knockouts (Figure 3.7C) validating MycE is promoting metastasis-associated gene expression at 
least on Cdh1.   
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Table 3.7 Co-localization frequency of MycE and metastasis associated genes  
Cell MycE-Cldn 
MycECtr-
CldnCtr 
MycECtr-
Cldn 
MycE-
CldnCtr 
MycE-
Wnt7a 
MycECtr-
Wnt7a 
MycE-
Cdh1 
MycECtr-
Cdh1 
4T1 24.4% 5.3% 10.3% 13.6% 23.2% 9.0% 22.5% 6.4% 
67NR 12.0% 15.4% 6.9% 10.7% 18.3% 13.5% 19.6% 10.7% 
NIH3T3 6.8%    7.8%    
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Figure 3.7 Chromatin interaction between MycE and metastasis-associated genes in trans 
(A) The co-localization of MycE and Cldn3,4. 
(B) Gene expression in MycE knockouts. By qRT-PCR measurement of transcription in 13 MycE 
knockouts, Cldn3, Abhd11, Cdh1 and Wnt7a were significantly down-regulated as well as Myc. 
(C) Gene expression in Myc overexpressed MycE knockouts. In Myc overexpressed 
4T1_Cas9_koMycE_Myc cells, Cdh1 expression were not rescued compared with control 
4T1_Cas9_knoMycE_Ctr and its parental 4T1_Cas9 cells by qRT-PCR. 
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Chapter 4 
4.1 Introduction 
Unbiased screens, such as meiotic genetic susceptibility analysis, provides one method to 
begin to implicate pathways and genes in difficult-to-observe phenomenon.  Genetic screens can 
be performed to identify inherited polymorphisms that affect the final outcome of a phenotype, 
such as overt metastatic disease, without the need for pre-existing hypotheses about where in the 
metastatic cascade a particular factor acts. SNPs that are found to be associated with differential 
metastatic capacity in tumor progression can be used to retrospectively construct the probable 
biology along the metastatic cascade on which a gene or genes act without direct observation, 
much like clues used to reconstruct events at a crime scene. 
Based on this premise, we developed a genetic screen that demonstrated a significant role 
of inherited polymorphisms in the progression of a transgene-induced model of mammary tumor 
metastasis130,131. We utilized a strategy that integrated a subtractive SNP screen between closely-
related inbred strains with differing metastatic potentials to identify polymorphisms that were 
enriched for metastasis suppressing functions126. To further filter the SNPs, we subsequently 
focused only on SNPs that mapped within DHS of a publicly available mouse mammary tumor 
cell line. This strategy was based on human studies that indicate that the majority of disease-
associated polymorphisms are non-coding124 and therefore likely mediate their effects through 
subtle changes in gene transcription125,126. Putative candidate genes were identified by proximity 
to polymorphic DHS sites and subsequent analysis indicated that these candidates were enriched 
for factors and mechanisms associated with progression in both mouse models and human breast 
cancer patients126. 
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Despite the success of these studies, there are limitations such as the ignorance of distal 
regulatory elements that connect with certain metastasis associated genes. Therefore, we refine 
the integrated strategy by specifically focusing on candidate genes enriched for the quiescent-to-
proliferative conversion by using BACh sites identified in three cell lines of the 4T1 cell line 
series, which represent different stages along the metastatic cascade182.  Furthermore, BACh-to-
gene assignment was refined by the use of RNAPII ChIA-PET analysis, which specifically maps 
chromatin interactions mediated by RNA polymerase II, to provide physical evidence of 
polymorphic BACh interaction with gene promoters.  
The work in this chapter was mostly done by Kent Hunter group in National Cancer 
Institute. I have contributed in doing the chromatin interaction related analysis.   
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4.2 Materials and Methods  
Computing environment 
All computations at NCI were performed on the NIH helix/biowulf system, documentation of 
which is available at https://helix.nih.gov.  We used R computing environment, Perl scripts, 
Bedtools, and UCSC liftOver for most of the analyses. 
Identification of polymorphic BACh sites 
The workflow consisted of the following: 1) the BACh data were filtered for the regions 
overlapping with polymorphic sites.  Since the BACh data were generated in Genome Build 
mm9, we used UCSC mm9 snp128 data to restrict the BACh sites.  2) Vcf were filtered to retain 
the SNPs that overlap with the BACh present in the 4T1, 4T07 and 67NR cell lines.  3) SNPs 
were removed in the BACh that are present in the mouse FVB/NJ strain. 
Effect of Pioglitazone treatment on pulmonary metastases 
1x105 cells/mouse of the mammary tumor cell line 6DT1 were orthotopically implanted into the 
fourth mammary fat pad of female FVB/NJ mice (6-8 weeks old).  Ten days post-implantation, 
all of the animals were combined into a single cage then randomly assigned to treatment or 
control group by alternating assignment to new cages. Pioglitazone (100µM) or vehicle (DMSO, 
0.17%) was added to drinking water 10 days post tumor implantation and available to mice ad 
libitum.  Drinking water with Pioglitazone or DMSO was refreshed every week. Tumor growth 
was monitored and animals were euthanized 28 days post implantation. Tumors and lungs were 
evaluated for weight and surface metastases respectively. The experiment was performed twice 
and the results were analyzed using  the Mann-Whitney test and the results of the independent 
experiments combined using the weighted Z-method183. All procedures were performed as 
approved by the NCI-Bethesda Animal Care and Use Committee. 
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Effect of Dexamethasone treatment on pulmonary metastases 
1x105 cells/mouse of the mammary tumor cell line 6DT1 were orthotopically implanted into the 
fourth mammary fat pad of female FVB/NJ mice (6-8 weeks old).  10 days post-implantation all 
of the animals were combined into a single cage, then randomly assigned to treatment or control 
group by alternating assignment to new cages.  Dexamethasone was administered by 
intraperitoneal injection at 5 mg/kg of body weight in PBS daily for 21 days.  At the end of the 
treatment period, animals were euthanized and tumor weights and pulmonary metastatic lesions 
enumerated.  The experiment was performed twice and the results of the Mann-Whitney test 
were combined the weighted Z-method183.  All procedures were performed as approved by the 
NCI-Bethesda Animal Care and Use Committee. 
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4.3 Results 
Correlation of the number of BACh sites in the 4T1 cell line series with metastatic 
potential 
To identify BACh that are associated with the colonization of metastatic secondary sites, 
analysis of three of the cell lines from the mouse 4T1 mammary tumor cell line panel was 
performed. BACh analysis was performed to identify metastatic 4T1 cell specific sites (Figure 
4.1A). Based on the hypothesis, genes associated with these BACh would be enriched for factors 
necessary for the conversion of dormant solitary tumor cells to a proliferative multicellular 
metastatic lesion.   
Biological duplicate BACh analysis was performed on each cell line. Analysis comparing 
the replicate samples indicated a high degree of reproducibility (R>= 0.90) (Figure 4.2A).  The 
data for the replicate experiments were pooled and the BACh patterns for the three cell lines 
examined. Comparison of the BACh between the different cell lines revealed a total of 3580 
4T1-specific BACh sites that might be associated with metastasis susceptibility genes (Figure 
4.1B). In addition, an unexpected significant inverse correlation was observed between the 
malignancy of the cell lines and the number of BACh, with a total of 43,112 BACh observed in 
the benign 67NR cell line, 38,106 in 4T07, and 27,156 in the fully metastatic 4T1 cell line. To 
confirm that the loss of BACh was not due to a technical artifact, the data were analyzed for a set 
of reference BACh in each cell line (Figure 4.2A, 4.2B and Figure 4.1C).  The analysis indicated 
that approximately 90% of the reference BACh were successfully captured in each cell line, 
indicating that the decrease in BACh across the cell lines was not likely due to the relative 
efficiency of BACh capture in each line (Figure 4.1C). 
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The relative position of the BACh to known TSS was then examined to determine if 
specific classes of BACh were progressively lost during increased metastatic progression. The 
number of BACh sites associated with promoter elements - defined as regions 2.5 kb upstream of 
the transcriptional start site to 2.5 kb downstream - was approximately equivalent across all three 
cell lines. This suggested that approximately the same number of genes were transcriptionally 
active across the cell lines; subsequent analysis of RNA-seq data was consistent with this 
interpretation. In addition, RNA content per cell was not found to be significantly different 
among the three cell lines, indicating that a general decrease in transcription had not occurred. In 
contrast to the promoter BACh, BACh within introns, overlapping exons, or residing either 
upstream or downstream of TSS all showed progressive loss across the cell lines. Analysis of the 
relative position of the retained versus lost BACh revealed that BACh farther away from 
transcriptional start sites were preferentially lost as malignancy increased (Figure 4.2D).  
Stratification by genomic position further revealed that preferential loss of distant BACh was 
restricted to BACh outside of gene bodies, suggesting a progressive closure of potential distant 
enhancer elements as the mammary tumor cell lines gained metastatic potential. 
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Figure 4.1 Characterization of chromatin accessibility by BAChs 
(A) Schematic of the different classes of Benzonase accessible chromatin sites (BAChs) for the 
4T1 cell line series. Left is a depiction of the tumor phenotypes in three cell lines, with the 
localized 67NR tumor at the top, the disseminating but not metastatic 4T07 in the middle, and 
the highly metastatic 4T1 tumor at the bottom. BACh sites are represented by the green peaks. 
The 4T1-specific BAChs are indicated by the red box.  
(B) Venn diagram of the BACh site overlap in the 67NR, 4T07 and 4T1 cell lines. 
(C) Lineage plots of BAChs in the 4T1 cell line series. Dark blue represents sites present in 
67NR that persist or reoccur in 4T07 and 4T1. Brown indicates BACh sites that appear in 4T07 
that persist in 4T1. Light blue indicates BACh sites that appear specifically in 4T1. Numbers in 
the lineage plots indicate the number of BACh sites in each category for the three cell lines. The 
annotation for each genomic and sub-genomic analysis is indicated above the individual lineage 
plots. 
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Figure 4.2 Evaluation and characterization of BACh sites 
(A) BACh site replication, overlap and genomic annotation data for the duplicate samples for 
67NR, 4T07 and 4T1 cell line.  The left figure in each row shows the correlation of the BACh for 
each duplicate sample. The Venn diagram in the center displays the overlap of BACh identified in 
the cell line replicates. The histogram on the right shows the overlap of DHS with respect to gene 
features.  
(B) Lineage plots of BACh in the 4T1 cell line series. Dark blue represents sites present in 67NR 
that persist or reoccur in 4T07 and 4T1.  Brown indicates BACh sites that appear in 4T07 that 
persist in 4T1. Light blue indicates BACh sites that appear specifically in 4T1.  Numbers in the 
lineage plots indicate the number of BACh sites in each category for the three cell lines.  The 
annotation for each genomic and sub-genomic analysis is indicated above the individual lineage 
plots.  
(C) BACh sites evaluation by PRC. A total of 8,587 peaks were found to be present in all 133 
samples. PRC was obtained to evaluate the level of digestion by Benzonase. Our pooled samples 
with PRC of 90% or greater indicate that all 8,587 sites were present in the sample. Two 
biological replicates with acceptable PRC were selected and pooled for each cell line, and each 
pooled data set showed over 90% PRC. 
(D) Plot of the relative position of persistent or lost Benzonase accessible chromatin sites 
(BAChs) to transcriptional start sites (TSS) across the 4T1 cell line series. BACh sites that are 
maintained across the cell lines are represented by the blue line, while lost BAChs are represented 
by the red line.  
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Identification of polymorphic BACh sites and associated genes 
Next, we sought to filter the 3580 4T1-specific BACh for those likely to be associated 
with inherited susceptibility to developing metastatic disease. Previously, we demonstrated that a 
subtractive strategy comparing phylogenetically closely-related mouse strains with different 
metastatic capacities was an effective method of identifying potential metastasis-associated 
genes. Here, by focusing on the 3580 4T1-specific BACh sites and multiple paired high- and 
low-metastatic mouse strains, we further refined this strategy to identify a common set of 
metastasis-associated candidates enriched for genes potentially involved in the dormant-to-
proliferative colonization switch. Five different mouse strain pairs were selected for this analysis 
based on close phylogenetic relationships and positions on either end of the inherited metastatic 
efficiency spectrum (Figure 4.3A, 4.3B).   
To identify polymorphic BACh that might influence the transcription of metastasis-
associated genes, SNPs present in the low metastatic strain were extracted from those present in 
its closely-related highly metastatic relative to enrich for variants that suppress metastatic disease 
(Figure 4.3C). To specifically enrich for those polymorphisms affecting transcription of potential 
colonization-suppressing genes, the variants were filtered for those that fall within the 3580 4T1-
specific BACh. This resulted in 1053-7396 SNPs present in 339-2254 BACh sites for the five 
strain pair comparisons (Table 4.1). 
It is known that enhancer elements can be at a considerable distance from their target 
genes and chromosomal looping can result in enhancer-promoter contacts that reach over 
intervening genes. Polymorphic BACh-gene assignments based only on proximity therefore 
likely results in a significant degree of both false-positive and false-negative associations. To 
improve the accuracy of candidate gene discovery we therefore performed RNAPII ChIA-PET in 
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the 4T1 cell line identify RNAPII mediated chromosomal contacts between polymorphic BACh 
and active or poised promoters. Polymorphic BACh were used to identify initial intra-
chromosomal loops connecting the BACh with distant positions. The initial ChIA-PET end pairs 
were then used to seed a walking strategy to identify gene promoters in close proximity to 
polymorphic BACh via intra-chromosomal looping (Figure 4.3C). A total of 358,508 paired end 
tags were identified by the RNAPII ChIA-PET analysis in 4T1 cells, of which 85,853 
represented intra-chromosomal looping events.  Interestingly, a similar reduction of the number 
of RNAPII binding peaks was observed across the 4T1 cell line series as seen for the BACh sites, 
with 29971 RNAPII binding peaks in 4T1, 41809 in 4T07 and 40513 in 67NR cells (Figure 
4.4A). Similar trend of BACh sites and RNAPII binding peaks, indicates a positive correlation of 
chromatin accessibility and transcriptional activity.  
Applying the polymorphic BACh/ChIA-PET walking strategy to each of the five mouse 
strain pairs resulted in the identification of 587-2123 genes (Table 4.1) that were in contact with 
polymorphic BACh and whose expression might therefore be influenced by the inherited 
polymorphisms. The resulting gene lists for each of the mouse strain pair subtractions were then 
compared to identify a core set of candidate metastasis susceptibility genes. 338 genes were 
found to be in common in the five separate analyses, potentially representing a common set of 
functions necessary for metastatic progression in the PyMT mouse mammary tumor model 
(Table 4.2; Figure 4.3D). To determine whether a significant fraction of these genes might 
represent identity by descent due to the shared inheritance of common inbred mouse strains, the 
overlap of polymorphic BACh and SNPs was also examined. Only nine polymorphic BACh 
were common to the five different strain combinations (Figure 4.4B), and no SNPs were shared 
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(Figure 4.4C), indicating that different inherited polymorphisms and haplotypes were tagging the 
same set of genes through long range intra-chromosomal architecture. 
To determine whether the core metastasis susceptibility candidate genes might share 
common transcriptional regulatory elements, promoter motif analysis was performed using the 
GREAT tool.  Five motifs were observed to be over-represented in all five strain comparisons, 
including the previously characterized Sp1 and ELK1 transcription factor binding sites (Table 
4.3), which is consistent of the promoter binding motif analysis in Chapter 3 (Figure 3.1C). The 
three additional sequence motifs have not previously been associated with transcription factor 
binding. These motifs may therefore represent binding sites for novel transcription factors with 
important roles in metastatic breast cancer progression (Table 4.3).   
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Figure 4.3 Gene identification by ChIA-PET and polymorphic BACh analysis 
(A) Phylogenetic relation of the pairs of high- (blue) and low- (red) metastatic mouse strains used in 
the analysis are shown.  
(B) Histogram of relative metastatic capacity in the selected strain pairs across the full inbred strain 
survey. Y-axis represents the average number of metastases observed per animal. X-axis indicates 
the identity of the inbred strain bred to the PyMT model. The number of animals analyzed in each 
breeding is indicated below the x-axis. Blue bars indicate strains that displayed no significant 
difference in metastatic capacity compared to the original FVB background of the PyMT mammary 
tumor model. Red bars indicated strains that showed statistically significant reduction of metastatic 
disease, calculated by pairwise Mann-Whitney t tests.  
(C) Schematic of the analytic genome-wide strategy used to identify potential metastasis 
susceptibility genes. Single nucleotide polymorphisms that distinguish the phylogenetically highly 
related high and low strains were filtered for those that fall within 4T1-specific BACh sites and are 
therefore most likely associated with alterations in transcriptional activity. The polymorphic BACh 
sites were then used to nucleate a walking strategy with the RNAPII ChIA-PET looping data to 
identify gene promoters that were in contact with the BACh site. (D) Venn diagram showing 338 
genes in common were identified as having their transcriptional start sites tagged by the polymorphic 
BACh-ChIA-PET walking strategy in all five strain pair combinations.  
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Figure 4.4 Venn diagrams of BACh sites, RNAPII binding peak and SNPs 
(A) Similar amount of shared and unique sites was identified in BACh sites and RNAPII binding 
peaks. 
(B) Analysis of the overlap of polymorphic DHS in the five comparisons revealed only 9 
polymorphic BACh in common.  
(C) SNP analysis in the polymorphic BACh revealed that no variants were common for the five 
strain pair comparisons. 
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Table 4.1 Results of Integrated DHS, SNP and ChIA-PET screening strategy 
Mouse Strain 
Pairs 
RF subtracted 
by AKR 
C58 subtracted 
by C57BL10 
C57BR subtracted 
by C57BL10 
SEA subtracted 
by BALB 
MOLF 
subtracted by 
CAST 
SNPs in DHS 1053 1234 1236 2571 7396 
Polymorphic DHS 339 373 399 802 2254 
Tagged TSS 587 616 690 1155 2123 
 
Table 4.2 Putative Common Core Metastasis Susceptibility Genes 
Gene Symbol 
    
1110008P14Rik Csnk2b Gstp1 Il1a Pacsin3 Src 
1700092M07Rik Ctsw Gstp2 Il1b Pak6 Srrm2 
1810009A15Rik Cyb561a3 Gtf2h4 Incenp Pcnxl3 Ssfa2 
1810055G02Rik D030056L22Rik Guca1b Ints5 Pfdn4 Ssna1 
4933433C11Rik D17H6S53E H2-D1 Itprip Phf19 Ssrp1 
Abhd16a D17H6S56E-5 H2-K1 Jmjd8 Pigyl Sssca1 
Abt1 D730039F16Rik H2-Q4 Kat5 Pitpnm1 Stx5a 
Adrm1 Dagla H2-T23 Kremen2 Pkmyt1 Surf4 
Agpat2 Ddah2 H2-T24 Lama5 Pmepa1 Surf6 
Ahnak Ddb2 Hat1 Lnpep Pnpla7 Suv420h1 
AI462493 Ddr1 Hcfc1r1 Lpin2 Polr2g Synj2 
AI837181 Ddx39b Hist1h1a Lrrc26 Ppp1r18 Taf6l 
Alkbh3 Decr2 Hist1h1b Lrrn4cl Ppp2r5b Tceb2 
Anapc2 Dhx16 Hist1h1c Lrsam1 Procr Tgif1 
Anxa1 Dnmt3b Hist1h1d Lsm2 Prrc2a Thbs4 
Ap5b1 Doc2g Hist1h1e Ltbp3 Psat1 Thoc6 
Apom Dpf2 Hist1h1t Ly6g5c Psmd5 Tle4 
Arfgap2 Drap1 Hist1h2ab Ly6g6c Psors1c2 Tmem138 
Arhgap40 Dus3l Hist1h2ac Ly6g6f Rab31 Tmem151a 
Arhgef28 Dusp5 Hist1h2ad Lyst Rab3il1 Tmem179b 
Arpc5l Ecsit Hist1h2ae Lzts2 Rabepk Tmem203 
Arrdc1 Edem2 Hist1h2af Manbal Rad9a Tmem210 
Asb13 Eef1g Hist1h2ai Map3k11 Rbl1 Tmem223 
Atat1 Efemp2 Hist1h2ak Mdc1 Rbm39 Tmem258 
Atp5e Efna5 Hist1h2an Med22 Rela Tmem8 
Atp6v1g2 Ehbp1l1 Hist1h2bb Minpp1 Rgs19 Tnfrsf12a 
Atrn Ehmt1 Hist1h2bc Mroh8 Rin1 Tor4a 
Atrnl1 Ehmt2 Hist1h2be Mrpl11 Ring1 Tprn 
AU023871 Eif1ad Hist1h2bf Mrpl28 Rnaseh2c Traf1 
Axin1 Elof1 Hist1h2bg Mrpl41 Rnf208 Tsga10ip 
B3gat3 Eml3 Hist1h2bh Mrps18b Rnf24 Ttc9c 
B3gnt1 Fads3 Hist1h2bm Msh5 Rom1 Tubb4b 
B4galt7 Fam166a Hist1h2bp Mta2 Romo1 Tubb5 
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Bag6 Fam69b Hist1h2br Mtl5 Rpl35 Tut1 
Banf1 Fam89b Hist1h3a Mus81 Rpl7a Ubxn1 
Blcap Fbxw2 Hist1h3b Mybpc3 Rpl9-ps6 Uqcrb 
Brd3 Fen1 Hist1h3c Myl12a Rpn2 Urm1 
Brms1 Fibp Hist1h3d Myl12b Rps21 Vars 
Cables2 Flot1 Hist1h3e Ncs1 Rrbp1 Vars2 
Camsap1 Flywch2 Hist1h3f Ndor1 Sart1 Vwa7 
Ccdc147 Fnbp4 Hist1h3g Ndufv1 Scd2 Wdr43 
Ccdc64b Fosl1 Hist1h3h Nelfb Scgb1a1 Wdr5 
Ccdc85b Frmd8 Hist1h3i Nelfe Scyl1 Wdr74 
Ccdc94 Fth1 Hist1h4a Neu1 Serinc5 Wdr85 
Cd248 Gal3st3 Hist1h4b Neurl1b Serpinb6a Xrn2 
Cdk2ap2 Ganab Hist1h4c Nfe2l2 Sf3b2 Yif1a 
Cds2 Ggta1 Hist1h4d Nfkbil1 Sgms1 Zbtb3 
Cep110 Ghrh Hist1h4f Nfs1 Skiv2l Zc3h6 
Cep250 Gm10197 Hist1h4h Nrarp Slc25a12 Zc3h8 
Cfl1 Gm10762 Hist1h4j Nrm Slc25a45 Zfp184 
Chka Gm10767 Hist1h4k Nudt8 Slc29a2 Zfp213 
Ckap2l Gm10800 Hnrnpa3 Nxf1 Slc34a3 Zfp653 
Cldn6 Gm16181 Hnrnpul2 Ola1 Slc3a2 Zmynd19 
Cldn9 Gm711 Hsd17b12 Olfr1424 Smc3 
 
Clic1 Gm757 Hspa1b Osbpl2 Smndc1 
 
Cnn1 Golga1 Hspa5 Ovol1 Snx32 
 
Commd7 Gpank1 Ier3 P2rx3 Snx9 
 
 
Table 4.3 Significantly enriched promoter motifs in core metastasis susceptibility candidate genes 
    Hyper FDR Q-Val   
Transcription Factor Motif 
RF 
subtracted 
from AKR 
C58 
subtracted 
from C57BL10 
C57BR 
subtracted 
from C57BL10 
SEA 
subtracted 
from BALB 
MOLF 
subtracted 
from CAST 
(no known TF) KRCTCNNNNMANAGC 1.90E-28 7.68E-28 2.03E-26 4.58E-20 2.93E-15 
Sp1 GGGCGGR 1.61E-06 0.028 2.72E-15 6.40E-13 2.53E-22 
 (no known TF) TTTNNANAGCYR 4.64E-15 1.45E-15 6.36E-12 2.63E-11 8.76E-06 
ELK1, member of 
ETS oncogene 
family 
SCGGAAGY 0.027 0.032 0.0065 9.88E-08 1.02E-05 
 (no known TF) GATTGGY  0.00064 0.0099 0.0035 0.0034 2.68E-05 
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Disease and function analysis of metastasis susceptibility candidates 
Literature searches were performed for the 338 candidate metastasis susceptibility genes 
to investigate previous associations with metastatic disease. Two genes (Brms1, Mta2) among 
the 338 have previously been extensively studied for their role in metastatic disease184,185.  
Moreover, an additional 30 genes have previously been implicated in phenotypes associated with 
metastatic disease, including invasion, migration, epithelial-to-mesenchymal transition (EMT) 
and prognosis, consistent with the screen enriching for metastasis-associated factors. 
To better understand the potential molecular and cellular functions represented from the 
338 genes, Ingenuity Pathway Analysis was performed. Disease and Function analysis revealed 
two major categories associated with the putative core gene set (Figure 4.5A; Table 4.4). The 
first category was formation of nucleosomes and DNA replication. The second association was 
with diabetes mellitus. shRNA-mediated knockdown of peroxisome proliferator-activated 
receptor (PPAR), a target molecule for diabetes, was therefore performed and found to increase 
metastatic capacity in a tumor-autonomous manner (Figure 4.5B, 4.5C). Treatment of animals 
with Pioglitizone, a PPAR antagonist, reduced metastatic capacity of the tumors (Figure 4.5D, 
4.5E). Together, these studies provide support that the metabolic diabetes mellitus axis may be 
part of the common breast cancer metastatic machinery that might be exploitable for clinical 
intervention of metastatic colonization. 
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Figure 4.5 Disease and functional pathway analysis 
(A) Disease and Function results of the Ingenuity Pathway Analysis of the core 338 genes.  
(B-E) Effects of Pparg (panels B and C) or Pioglitizone (panels D and E) on pulmonary 
metastases (B and D) and the primary tumor growth (C and E) of the 6DT1 allograft 
mammary tumor cells. The figure represents the combined results of two independent 
experiments for each experimental condition. P-values were calculated for each experiment by 
two-tailed Mann Whitney test, using Graph Pad Prism v 7, and subsequently combined using 
the weighted Z-method. 
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Table 4.4 IPA Disease and Function Analysis of Core Metastasis Susceptibility Genes 
Categories Diseases or Functions Annotation p-Value 
Cancer, Organismal Injury and Abnormalities, Reproductive 
System Disease breast or ovarian cancer 8.77E-03 
Cancer, Organismal Injury and Abnormalities breast or ovarian carcinoma 2.04E-02 
Gene Expression transcription of RNA 1.39E-02 
Immunological Disease systemic autoimmune syndrome 3.06E-06 
Cancer, Endocrine System Disorders, Organismal Injury and 
Abnormalities, Reproductive System Disease ovarian cancer 2.09E-02 
Connective Tissue Disorders, Inflammatory Disease, Skeletal 
and Muscular Disorders Rheumatic Disease 5.97E-05 
Metabolic Disease glucose metabolism disorder 3.05E-03 
Connective Tissue Disorders, Inflammatory Disease, 
Inflammatory Response, Skeletal and Muscular Disorders inflammation of joint 1.90E-05 
Endocrine System Disorders, Gastrointestinal Disease, 
Metabolic Disease diabetes mellitus 1.01E-03 
Inflammatory Disease chronic inflammatory disorder 4.33E-04 
Endocrine System Disorders, Gastrointestinal Disease, 
Immunological Disease, Metabolic Disease insulin-dependent diabetes mellitus 3.73E-11 
Connective Tissue Disorders, Immunological Disease, 
Inflammatory Disease, Inflammatory Response, Skeletal and 
Muscular Disorders 
rheumatoid arthritis 2.07E-05 
Protein Synthesis polymerization of protein 8.84E-06 
Antimicrobial Response, Inflammatory Response antimicrobial response 1.36E-04 
Cell Death and Survival cell death of connective tissue cells 2.86E-02 
Cellular Assembly and Organization, DNA Replication, 
Recombination, and Repair formation of nucleosomes 3.03E-18 
Cellular Development, Cellular Growth and Proliferation, 
Connective Tissue Development and Function proliferation of fibroblast cell lines 3.00E-03 
Cancer cell transformation 6.82E-03 
Post-Translational Modification, Protein Synthesis heterotetramerization of protein 2.73E-17 
Cancer, Organismal Injury and Abnormalities, Reproductive 
System Disease cervical tumor 1.47E-02 
Embryonic Development size of embryo 6.42E-03 
Organismal Injury and Abnormalities, Reproductive System 
Disease noninflammatory cervical disorder 2.86E-02 
Antimicrobial Response, Inflammatory Response antiviral response 1.30E-03 
Lipid Metabolism, Small Molecule Biochemistry metabolism of phospholipid 9.33E-04 
Lipid Metabolism, Small Molecule Biochemistry synthesis of phospholipid 2.16E-04 
Cell Death and Survival cell death of melanoma cell lines 5.25E-03 
Organismal Injury and Abnormalities, Tissue Morphology size of lesion 6.22E-03 
Cell Cycle G2 phase 9.55E-03 
DNA Replication, Recombination, and Repair repair of DNA 1.74E-02 
Cancer, Organismal Injury and Abnormalities invasive cancer 2.36E-02 
Cell Death and Survival apoptosis of lung cancer cell lines 3.13E-03 
Cell Death and Survival killing of cells 4.80E-03 
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Cardiovascular Disease, Organismal Injury and 
Abnormalities, Tissue Morphology size of infarct 2.88E-03 
Cellular Development, Cellular Growth and Proliferation cell proliferation of cervical cancer cell lines 9.37E-03 
Cell Death and Survival cell death of sarcoma cell lines 1.94E-02 
Cellular Development, Hematological System Development 
and Function, Hematopoiesis, Tissue Development differentiation of megakaryocytes 1.12E-05 
Antimicrobial Response, Inflammatory Response antibacterial response 2.83E-03 
Cancer, Organismal Injury and Abnormalities, Reproductive 
System Disease invasive breast cancer 2.55E-02 
Carbohydrate Metabolism, Lipid Metabolism, Small 
Molecule Biochemistry synthesis of phosphatidic acid 8.21E-03 
Carbohydrate Metabolism, Lipid Metabolism, Molecular 
Transport, Small Molecule Biochemistry concentration of phosphatidic acid 1.21E-02 
Cellular Response to Therapeutics sensitivity of cells 1.40E-02 
Cell Cycle, DNA Replication, Recombination, and Repair DNA recombination 2.41E-02 
Respiratory Disease chronic pulmonary disease 2.60E-02 
Cell Cycle, Connective Tissue Development and Function cell cycle progression of fibroblast cell lines 1.29E-03 
Cell Cycle, DNA Replication, Recombination, and Repair recombination of cells 5.00E-03 
Cell Cycle, Cellular Development, Connective Tissue 
Development and Function senescence of fibroblast cell lines 5.48E-03 
Organismal Development abnormal morphology of tail 5.98E-03 
Gene Expression binding of NFkB binding site 7.70E-03 
Cancer, Cell Death and Survival, Organismal Injury and 
Abnormalities, Tumor Morphology cell death of osteosarcoma cells 1.50E-02 
Cancer, Dermatological Diseases and Conditions, Organismal 
Injury and Abnormalities papilloma 1.65E-02 
Cancer, Organismal Injury and Abnormalities, Tissue 
Morphology quantity of tumor 2.46E-02 
Cell Cycle G2 phase of tumor cell lines 2.91E-02 
DNA Replication, Recombination, and Repair breakage of DNA 1.02E-03 
DNA Replication, Recombination, and Repair, Gene 
Expression methylation of DNA 5.14E-03 
Organismal Injury and Abnormalities, Tissue Morphology volume of lesion 6.06E-03 
Lipid Metabolism, Molecular Transport, Small Molecule 
Biochemistry accumulation of triacylglycerol 1.36E-02 
Cell Cycle, DNA Replication, Recombination, and Repair homologous recombination of cells 1.36E-02 
Dermatological Diseases and Conditions, Organismal Injury 
and Abnormalities hyperkeratosis 1.48E-02 
Hereditary Disorder, Neurological Disease, Organismal Injury 
and Abnormalities spinocerebellar ataxia 1.60E-02 
Connective Tissue Development and Function, Tissue 
Morphology quantity of white adipose tissue 1.80E-02 
Cancer, Organismal Injury and Abnormalities tumorigenesis of benign tumor 2.24E-02 
Organismal Development abnormal morphology of blastocyst 2.85E-02 
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Canonical pathway analysis of metastasis susceptibility candidates 
The core gene set was enriched for molecules associated with cell-cell and cell-matrix 
interactions as well as motility and related downstream signaling pathways (Figure 4.6A).  In 
addition, in agreement with previous results126, aryl hydrocarbon receptor signaling was also 
implicated, as well as glucocorticoid receptor signaling, inflammatory and other immunological 
components.  
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Figure 4.6 Pathway analysis of 338 identified genes  
Canonical Pathway results of Ingenuity Pathway Analysis of the 338 core gene set.  Relative 
strength of the p value of pathway association is indicated by the shade of red, with the darker 
red indicating a smaller p value. The range of p values observed is indicated at the top of the 
figure.  
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Metastasis associated genes predict patient prognosis 
 As stated previously, we have identified 743 genes over-expressed in metastatic 4T1 cells 
and 338 metastasis susceptibility genes that potentially promote metastasis progression by 
comparative analysis of cell lines and mouse strains, respectively. We then further identified 25 
genes that are shared with these two gene lists: Anxa1, Arrdc1, Cldn6, Ctsw, Hist1h1b, 
Hist1h2ab, Hist1h2bb, Hist1h2bc, Hist1h2be, Hist1h2bm, Hist1h2bp, Hspa1b, Il1a, Il1b, Incenp, 
Nrarp, Ovol1, Pak6, Pmepa1, Procr, Rom1, Scd2, Tmem223, Tprn, Tubb4b. Almost all these 
genes show trends towards poorer patient survival if they are amplified, consistently with 
positive gene expression correlation with imcreased malignancy across 4T1 cell line series. 
Among these genes Tmem223 was significantly associated with patient prognosis when the gene 
was amplified (Figure 4.7 A, C). Other genes, such as Nrarp, trended, but were not significantly 
likely due to the relatively low fraction of patients with gene amplification (Figure 4.7B, D). 
These data are consistent, however, with the ability of this strategy to identify important 
metastasis-associated genes that individually may contribute to poor prognosis in small 
subgroups of at-risk breast cancer patients.   
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A
B
C
D
Figure 4.7 Distinct chromatin interactions and survival analysis on identified metastasis-
associated genes  
(A) Chromatin interactions with Tmem223 gene in 4T1 cell series. The green line indicates gene 
promoter. The red lines indicate enhancers. 
(B) Survival analysis of Tmem223 in humanbreast cancer patients. 
(C) Chromatin interaction with Nrarp gene in 4T1 cell series. The green line indicates gene 
promoter. The red line indicates enhancer. 
(D) Survival analysis of Nrarp in human breast cancer patients. 
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4.4 Discussion 
Metastasis remains a significant problem for the management of breast cancer. Mortality 
can be attributed to metastatic disease and its sequelae, rather than the effects of the originating 
primary tumor.  However, despite the importance of this process for patient outcome, relatively 
little is known regarding the events that drive the metastatic cascade. A major reason for this 
ignorance is the difficulty of obtaining appropriate tissue samples to perform in-depth genomic 
characterizations. Metastatic lesions are usually not surgically removed, and those that are 
resected are usually confounded by treatment186 which may select for events associated with 
therapy resistance rather metastasis formation.  In addition, biopsies of metastatic lesions in 
untreated patients at diagnosis often suffer from low tumor content187 or necrosis186. Furthermore, 
most metastatic lesions are not accessible to biopsy and repeated biopsies of multiple lesions 
within individuals increases patient morbidity.  As an added challenge, since metastasis within 
patients exhibit significant heterogeneity at both the biomarker188–190 and genomic levels191,192, 
selective biopsies may not capture the full complexity of events associated with tumor 
progression.   
Intriguingly, analysis of patient samples to date has not provided convincing evidence for 
the existence of metastasis driver genes193–196. This may be due to limited numbers of samples 
screened.  However, studies to date suggest relatively few new coding mutations in metastases 
compared to the primary tumor, and no obvious recurrent mutations in genes or pathways have 
yet been described.  Current efforts to address the question of metastasis driver genes in human 
cancer are underway, utilizing biopsy or archival materials (reviewed in197).  These studies, 
however, are limited to a relatively small number of pre-selected genes and will therefore not 
have the ability to identify novel and/or unexpected events. Furthermore, these studies also do 
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not address the role of non-coding events or epigenetic events that may underlie metastatic 
ability. 
Mouse models overcome many of these limitations and offer many advantages. (i) a 
readily available, renewable resource of tissue enables additional technologies to be applied to a 
genetically equivalent set of tissues over time; (ii) the ability to observe the full natural history of 
metastatic development, which is not possible in human cancers due to surgical resection and 
application of neo-adjuvant and adjuvant therapies; (iii) the existence of syngeneic allograft 
models that can be utilized to rapidly directly test hypotheses generated from genomic 
characterization; and (iv) sophisticated genetic engineering capacities allow examination of 
hypotheses in whole animals, including factors that may function through somatic 
microenvironmental effects rather than direct effects on tumor cells, an area of research that is 
precluded in most human studies. Data generated from exploitation of animal models therefore 
provide an important vehicle for hypothesis generation and testing that can subsequently be 
examined and verified in more restrictive human experimental systems. 
The core gene set of 338 genes are significantly enriched in metabolic, cell-cell contact 
and immune functions. Consistent with previous studies126,195,198,199, small molecule agents 
implicated from these analyses to impact these molecular processes were found to significantly 
affect metastatic progression, both positively and negatively, in these model systems. If these 
results are translatable into human patients, they might provide opportunities to complement 
current adjuvant therapies to further decrease or delay the occurrence of metastatic disease. 
The integrated strategy presented here provides a novel method to identify potentially 
important genes within the metastatic cascade. Encouragingly, a number of the genes in this core 
set have previously been associated with metastatic breast cancer, including Mta2185 and 
Dissertation          Jacqueline Jufen Zhu 
 110 
Brms1184. Further validation and characterization of additional genes within the core 338 gene 
set will likely provide evidence for additional metastasis susceptibility genes and valuable clues 
to the molecular mechanisms driving metastatic colonization.    
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Chapter 5: Conclusions, limitations and future 
directions 
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Chapter 5 
5.1 Summary of the findings 
Chromatin interaction and genome structure have been widely studied to explore the 
regulatory mechanism of gene transcription. However, still little is known about the role of 
chromatin organization in cancer progression. In my thesis, I have characterized the chromatin 
interaction in mammalian cells using different methods including super-resolution imaging and 
high-throughput sequencing. Besides the visualization of chromatin loop, I also interrogated the 
chromatin reorganization in breast cancer metastasis. Beyond, I integrated the chromatin 
interaction with polymorphic BACh sites to identify metastasis susceptibility genes and network.  
The chromatin looping was inferred by DNA sequencing data. However, nobody has ever 
seen exactly how the chromatin loops into functionally regulatory interactions. We applied the 
super-resolution microscopy iPALM to image the 3D structure of the distinct 13 kb chromatin 
loop up to 20 nm resolution laterally and axially. Unexpectedly, we observed a complex looping 
structure instead of a single chromatin loop inferred by ChIA-PET data. Though the structures of 
six individual images are positively correlated with Hi-C data, the ultrastructure of each structure 
is very different across cells, suggesting the heterogeneity of the chromatin looping that can 
hardly be detected by sequencing methods. 
As chromatin organization is associated with gene transcription and disease development. 
We have characterized the chromatin interaction in mouse breast cancer cell lines harboring 
differed metastatic potential to investigate the enhancer regulation in metastasis progression. By 
comprehensive comparison of transcription, chromatin accessibility and chromatin interaction in 
4T1 cell series, we identified metastasis-associated genes and enhancers. The enhancer 
distribution on metastasis-associated genes revealed a delicate regulatory system that one gene 
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can be regulated by multiple enhancers and one enhancer can also regulate multiple genes in 
metastasis. The multi-tasking enhancers connecting with multiple metastasis-associated genes 
were validated by CRISPR knockout to play important roles in regulating gene transcription and 
metastatic phenotypes, providing potential candidates for therapeutics in breast cancer metastasis.  
For breast cancer metastasis study, we further introduced mouse strains for genetic 
screening to identify metastasis susceptibility associated SNPs. By integrating chromatin 
accessibility and interaction with identified SNPs, we identified a core set of metastasis 
susceptibility associated genes. This set of genes include not only previously identified genes but 
also novel ones that associate with metastasis. Pathway analysis suggested a couple of canonical 
signaling pathways involved in metastasis progress. Of them, glucocorticoid receptor pathway 
was validated to promote metastasis by mouse implantation experiment resulting higher 
metastasis potential treated with dexamethasone.  
 Taken together of breast cancer analysis in both mouse cell lines and mouse strains, 
Tmem223 and Nrarp were identified to be associated with metastasis progression consistently. 
The survival rate analysis in human breast cancer patient showed the alterations on Tmem223 
and Nrarp led to poorer survival compared to no alterations, indicating the critical importance of 
fundamental studies.   
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5.2 Limitation of the studies 
The super-resolution imaging on chromatin interaction provided novel insights into the 
chromatin looping conformation. However, the structure of the chromatin interaction is not fully 
unraveled due to the limitations of the methods. Firstly, DNA FISH used to stain the target 
chromatin region including the loop and the tails is in single color so that we are not able to 
distinguish the loop and the tails, giving more difficulties to the following modeling analysis. 
Secondly, the penetration depth of iPALM microscopy is only 600 nm, which is theoretically 
sufficient to cover the target chromatin region, but taking the whole nucleus into account, the 
penetration depth might not be able to capture the intact target region. Thirdly, the DNA FISH 
staining efficiency is not ideal to allow all the probe oligos to attach to the chromatin. Ideally, we 
have 336 fluorophores in total to hybridized with the 33 kb DNA in a density of about 10 
fluorophore/kb, which enables the detection of DNA with at least one fluorophore per 
nucleosome. However, in fact we only got about 70 fluorophores in average for each copy of the 
chromatin, decreasing the labeling density about five-fold. Lastly, due to the efficiency of 
iPALM, limited images were acquired that might not fully reflect all the possible conformation 
of the chromatin loop, which are not representative or conclusive enough.   
In breast cancer metastasis study, we utilized the genetic screening for pairs of mouse 
strains to identify metastasis susceptibility associated SNPs, and integrated the SNPs with 
chromatin accessibility and interactions characterized in 4T1 mouse cell line series to identify 
metastasis susceptibility associated genes. Due to the limitations and difficulties of ChIA-PET 
technology and mouse strain cell collection, it is not realistic so far to characterize chromatin 
interaction in mouse strains instead of cell lines. Though 4T1 cell line series are from tumors in 
BALB/cJ mouse strain, the genetic background and genome organization of this in vitro model 
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can be different from mouse strains studied in this thesis. Transcriptionally, 4T1 cell series are 
triple negative; and the EMT is reversely correlated to metastasis, which is against the well-
established metastasis mechanism, suggesting 4T1 model could possibly have a distinct 
molecular mechanism regulating metastasis progression. Therefore, the transcription, chromatin 
accessibility and interaction in mouse strains may not be fully recapitulated by the analysis of 
4T1 cell lines.  
In my study, I interrogate the chromatin interaction and gene regulation in mouse models. 
To be more suggestive for understanding the mechanism in human and disease development, 
similar strategies could be applied in human cell studies.  
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5.3 Future directions 
Regarding technologies used to study genome biology, high throughput DNA sequencing 
leads an efficient way to study eukaryotic genome by capturing tons of pieces of chromatin 
interactions. Despite the advantages, limitations are nonnegligible. Currently, sequencing 
technologies characterize the genome of a cell population, so that we get an averaged or the most 
frequently occurred chromatin conformation, which lacks individual specificity. Addressing the 
genome organization of a single cell would be a trend in the future. Different from sequencing 
technologies, imaging is a complementary method that allows investigation in single cell, but 
with a shortcoming of low throughput. Besides the improvement in resolution, a high throughput 
operation in visualizing chromatin conformation could be pursued.  
In the aspect of biological significance of genome study, characterizing genome 
organization in primary human cells would be more informative and suggestive for finding cures 
to diseases. The future goal is to be able to dig out genome structure associated driving factors 
for disease genesis in each patient individual if desired, and rescue the abnormality using 
genome or epigenome editing tools.  
In terms of the philosophy beyond biology, I have got inspired through my doctoral study. 
I have been studying biology for 12 years, majoring in bio-engineering, microbiology and 
medical sciences for bachelor, master and PhD, respectively. I like sciences, including math, 
physics, chemistry, etc. Unlike the subjects that are quantitative, biology is hardly predictable 
due to the nature of lives. “Life is like a box of chocolate, you never know what you’re gonna 
get.” This is the most fun part for me, driving me to try to get closer to the truth of life. The 
ultimate goal for me to study biology is to find the universal rules for the living organisms, to 
answer the questions of who I am and where I am going. All the living organisms tend to live 
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better by cooperation following certain rules. Microorganisms cooperate to let some of them to 
evolve prior to the others. Cells in multicellular organisms cooperate to differentiate into 
different parts. Nucleus and organelles cooperate within the cell to maintain cellular function. 
Chromatin cooperate in the genome to regulate gene transcription. Even a slight change of the 
chromatin organization could lead to a severely different result. More important to me, it is not to 
cure diseases, not to understand the biology itself, but to find the balance and achieve the 
harmony between the nature and the mankind.  
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Appendices 
DNA  Deoxyribonucleic acid 
RNA  Ribonucleic acid 
ISH  In situ hybridization 
FISH  Fluorescence in situ hybridization 
CT  Chromosome territory 
Chr  Chromosome 
LAD  Lamina-associated domain 
ICD  Interchromosomal domain 
ESC  Embryonic stem cell 
BAC  Bacterial artificial chromosome 
ChIP-seq Chromatin immunoprecipitation sequencing 
ATAC-seq Transposase-accessible chromatin using sequencing 
3C  Chromosome conformation capture 
4C  Circular chromosome conformation capture 
5C  Chromosome conformation capture carbon copy 
Hi-C  High-throughput chromosome conformation capture 
ChIA-PET Chromatin interaction analysis using pair-end tag sequencing 
H3K27ac Histone 3 lysine 27 acetylation 
H3K4me3 Histone 3 lysine 4 trimethylation 
2D  Two-dimension 
3D  Three-dimension 
DHS  DNase Hypersensitive site 
BACh  Benzonase accessible chromatin 
TAD  Topologically associating domain 
CTCF  CCCTC-binding factor 
RNAPII RNA polymerase II 
YY1  Ying yang 1 
TALEN Transcription activator-like effector nucleases 
CRISPR Clustered regularly interspaced short palindromic repeats 
STORM Stochastic optical reconstruction microscopy 
PALM Photoactivated localization microscopy 
iPALM Interferometric Photoactivated localization microscopy 
SIM  Structural illumination microscopy 
STED  Stimulated emission depletion 
lncRNA Long non-coding RNA 
Xist  X-inactive specific transcript 
Firre  Functional intergenic repeating RNA element 
Xi  Inactive X chromosome 
Xa  Active X chromosome 
ICF  Instability facial anomalies 
T-ALL T-cell acute lymphoblastic leukemia 
SNP  Single nucleotide polymorphism 
CCD  CTCF-mediated chromatin contact domains 
TCRA  T-cell receptor alpha 
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PBS  Phosphate-buffered saline 
KOH  Potassium hydroxide 
SSC  Saline-sodium citrate 
EMCCD Electron-multiplying charge-coupled device 
NN  Nearest neighbor 
NJ  Neighbor joining 
TSP  Traveling salesman problem solver 
TSS  Transcription start site 
qRT-PCR Quantitative reverse transcription polymerase chain reaction 
HDR  Homology-directed repair 
H&E  hematoxylin and eosin 
PRC  Percent reference peak coverage 
ECDF  Empirical cumulative distribution 
K-S test Kolmogorov-Smirnov test 
EMT  Epithelial-to-mesenchymal transition 
PPAR  Peroxisome proliferator-activated receptor 
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